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Improvements	  in	  sequencing	  technologies	  have	  shifted	  the	  foundations	  in	  biology,	  ecology	  and	  
health.	   Traditionally,	   these	   sciences	   have	   dealt	   with	   small	   amounts	   of	   data	   that	   could	   be	  
analyzed	   using	   simple	   methods	   and	   computational	   tools.	   Today,	   they	   are	   confronted	   with	  
massive	  numbers	  of	   sequences	  within	   thousands	  of	   samples.	   These	   sequences	   represent	   the	  
DNA	  from	  microorganisms	  that	  inhabit	  diverse	  environments,	  from	  soils,	  oceans	  to	  the	  human	  
body.	   Additionally,	   the	   recent	   studies	   are	   now	  moving	   from	   simple	   snapshots	   to	   spatial	   and	  
temporal	  datasets	   to	   studying	   the	  distribution	  of	   these	  microbial	  guests.	  These	   larger	   studies	  
reveal	   the	   lack	   of	   computational	   methods	   and	   resources	   researchers	   have	   to	   circumvent	   to	  
understand	   the	   intrinsic	   patterns	   of	   their	   new	   sequence	   based	   studies.	   In	   this	   dissertation,	   I	  
present	   new	   computational	   tools,	   methods,	   and	   visualizations	   that	   allow	   microbiologists	   to	  
make	  sense	  of	  these	  massive	  studies,	  and	  the	  interesting	  results	  concerning	  human	  health	  that	  
can	  be	  obtained	  from	  microbial	  ecology	  studies.	  Also,	  I	  present	  a	  cloud	  computing	  method	  for	  
combining	   these	   larger	   studies,	   which	   has	   already	   produced	   potentially	   important	   health	  
insights	  into	  the	  temporal	  development	  of	  infants.	  Finally,	  I	  describe	  a	  new	  software	  tool,	  which	  
allows	  microbial	  ecology	  researchers	  to	  design	  and	  statistically	  power	  future	  studies	  based	  on	  
previously	   published	   studies.	   These	   novel	   components	   not	   only	   demonstrate	   the	   future	   of	  
microbial	  computational	  biology,	  but	  also	  show	  the	  kind	  of	  medical	  and	  ecological	  advances	  we	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  6.	  SitePainter	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  microbial	  community	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  in	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  hand.	  (A)	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  file	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  manipulation,	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  metadata	  loading	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processing	  menu,	  (3)	  coloring	  scheme	  and	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  interactive	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  The	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  -­‐diversity	  
analysis	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  relative	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Figure	  12.	  Evident	  GUI	  and	  illustration	  of	  the	  reanalysis	  of	  (75).	  A.	  Main	  GUI	  and	  demo	  version	  
of	  the	  study	  of	  interest;	  A1.	  Selections	  for	  study,	  sequences	  per	  sample,	  number	  of	  
subjects,	  samples	  per	  subject	  and	  number	  of	  iteration;	  A2.	  Analysis	  Menu:	  Demo	  (view	  
original	  study	  results),	  PCoA	  plots	  and	  alpha	  rarefaction	  plots	  (not	  implemented);	  C)	  
Output	  area	  showing	  the	  webGL	  PCoA	  plot.	  B.	  Effect	  of	  rarefaction	  on	  β	  diversity;	  B1.	  10	  
sequences	  per	  sample	  show	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  main	  patterns	  in	  the	  data	  set;	  B2.	  100	  
sequences	  per	  sample	  with	  3	  iterations	  we	  get	  back	  most	  of	  the	  pattern	  but	  it	  is	  clear	  that	  






I. Advancing	  analytical	  algorithms	  and	  pipelines	  for	  billions	  of	  microbial	  sequences	  
We	  are	  currently	  faced	  with	  daunting	  bioinformatics	  and	  computational	  challenges	  due	  to	  the	  
vast	  number	  of	  microbial	  sequences	  yielded	  by	  new	  sequencing	  technologies.	  This	  conundrum	  
has	   forced	   those	   researching	   microbial	   communities	   to	   reassess	   their	   computational	  
development	  techniques	  and	  move	  to	  formal	  software	  engineering	  methods.	  	  
This	  chapter	  describes	  the	  current	  computational	  methods	  and	  pipelines	   in	  microbial	  ecology,	  
and	   the	   multidimensional	   reduction	   techniques	   we	   can	   apply	   to	   compare	   large	   number	   of	  
samples	   and	   sequences.	   The	   material	   presented	   was	   published	   in	   (1),	   and	   my	   role	   as	   main	  
author	  was	  to	  collect	  and	  compare	  all	  the	  data	  about	  the	  software	  tools	  and	  multidimensional	  
reduction	  techniques,	  including	  their	  contributions	  to	  microbial	  ecology.	  
	  
Introduction	  
Recent	   innovations	   in	   sequencing	   technologies	   allowed	  microbial	   ecologists	   to	   advance	   from	  
analyzing	   a	   few	   hundred	   sequences	   per	   study	   to	   hundreds	   of	   millions	   (2)	   and	   (3)].	   These	  
quantitative	  differences	  in	  the	  amount	  of	  sequence	  data	  produce	  qualitative	  differences	  in	  the	  
types	  of	  studies	  that	  can	  be	  performed.	  For	  example,	  10	  years	  ago,	  characterization	  of	  a	  single	  
clone	   library	   from	   a	   single	   body	   site	   in	   one	   subject	   represented	   a	   substantial	   advance	   in	  
knowledge	   about	   the	   human	  body.	   A	   few	   years	   ago,	   quantifying	   interpersonal	   differences	   in	  
one	  body	  site,	  for	  example,	  the	  gut,	  represented	  a	  major	  advance	  [(4)	  and	  (5)].	  Three	  years	  ago,	  
performing	   a	  multi-­‐site	  microbial	   scan	   of	   the	   body,	   showing	   how	   the	  microbial	   communities	  
that	   live	  on	  the	  same	  person's	  body	  are	  clearly	  separated	  by	  body	  site,	  primarily	  skin,	  mouth,	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and	   stool	   (6).	   Now,	   with	   higher	   throughput	   sequencing	   technologies,	   we	   can	   observe	   the	  
dynamics	   of	   the	   human	   microbiota	   across	   multiple	   sites	   and	   individuals	   through	   time,	  
demonstrating	   that	  our	  microbial	   guests	   are	  highly	   volatile	  day-­‐to-­‐day	  even	   in	  healthy	  adults	  
(7).	  These	  examples	  also	  illustrate	  the	  daunting	  analytical	  challenges	  that	  microbial	  researchers	  
face	   to	   handle	   datasets	   that	   are	   ever	   increasing	   in	   size.	   These	   challenges	   range	   from	   simply	  
finding	   the	   right	  hypotheses	   to	   test,	   to	   finding	   the	  correct	  analytical	   tools	  and	  computational	  
power	   to	   test	   them,	   to	   finding	   the	  methods	   for	   visualizing	   the	   key	   results.	   Here	   we	   review	  
computational	   tools	  developed	   in	   the	   last	   three	  years	  and	  algorithms	  conceived	  over	   the	   last	  
few	  decades,	  but	  only	  recently	  applied	  in	  microbial	  ecology;	  we	  conclude	  with	  suggestions	  for	  
computational	   tool	   developers	   who	   wish	   to	   help	   the	   field	   continue	   its	   rapid	   pace	   of	  
development	  over	  the	  next	  few	  years.	  
Microbial	  diversity	  analysis	  tools	  
	  
As	   16S	   rRNA	   and	   shotgun	   metagenomic	   datasets	   grow	   dramatically,	   the	   need	   for	   easily	  
accessible,	   well-­‐documented	   and	   well-­‐tested	   tools	   in	   the	   form	   of	   a	   pipeline	   becomes	  
increasingly	  critical.	  In	  particular,	  the	  complexity	  of	  what	  is	  considered	  a	  ‘standard’	  analysis	  has	  
increased	   rapidly,	   from	   small	   trees	   and	   pie	   charts	   to	   advanced	   analyses	   incorporating	  
multivariate	   statistics,	   machine	   learning,	   and,	   increasingly,	   explicitly	   spatial	   and/or	   temporal	  
analysis	   (Figure	  1).	  These	  new	  challenges,	  and	  especially	   the	  need	  to	   integrate	  multiple	  tools,	  
have	   forced	   researchers	   to	   move	   from	   ad	   hoc	   scripts	   developed	   in	   numerical	   computing	  
environments	  such	  as	  R	  (8)	  or	  MATLAB	  (9)	  to	  more	  general	  libraries	  that	  provide	  solutions	  to	  a	  
specific	   research	   niche.	   Examples	   include	   vegan,	   which	   provides	   statistical	   functions	   for	  
vegetation	   (and	   other)	   ecologists	   (10);	   ade4,	   which	   allows	   exploratory	   analyses	   for	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environmental	  sciences	  (11);	  and	  ape,	  which	  provides	  methods	  for	  phylogenetics	  and	  evolution	  
(12);	   see	   Table	   1.	   However,	   developing	   expertise	   in,	   appropriately	   formatting	   data,	   loading	  
large	  datasets	  and	  transferring	  datasets	  among	  multiple	  packages	  can	  be	  time-­‐consuming:	  for	  
example,	  see	  the	  ‘Methods’	  section	  and	  reference	  list	  of	  (13).	  
	  
Figure	  1.	  Moving	  away	  from	  pie	  charts	  and	  trees,	  towards	  current	  analytical	  methods.	  With	  a	  
few	   sequences	   from	   a	   small	   number	   of	   samples,	   pie	   charts	   and	   trees	   were	   sufficient	   for	  
comparing	   microbial	   community	   samples.	   In	   contrast,	   with	   modern	   technologies	   that	   allow	  
sequencing	   large	  number	   of	   samples	  with	  millions	   of	   reads,	   the	  new	  analysis	   ‘gold-­‐standard’	  
has	   moved	   towards	   deploying	   new	   tools.	   Here	   we	   show	   data	   from	   Ref.	   (7)	   analyzed	   with	  
several	  methods:	  TopiaryExplorer	  (14)	  allows	  visualization	  of	  large	  trees	  in	  the	  context	  of	  per-­‐
sample	  data,	   in	   this	   example	   visualizing	   the	  GreenGenes	   reference	   tree	   colored	  by	  body	   site	  
matches	  (red	  –	  skin,	  blue	  –	  stool,	  green	  –	  oral),	  showing	  pie	  charts	  of	  most	  abundant	  sequences	  
and	  zooming	   into	   the	  different	  clades;	  QIIME	  PCoA	  plot	   comparing	  all	   samples	  color	  by	  body	  
site	  (red	  –	  stool,	  blue	  –	  oral,	  orange	  –	  skin),	  PCoA	  with	  explicit	  time	  axis	  and	  tracing	  to	  follow	  
individuals	   over	   time	   in	   each	   body	   site,	   allowing	   visual	   inspection	   of	   the	   changes	   over	   time	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(female:	  red	  –	  gut,	  blue	  –	  oral,	  orange	  –	  skin;	  male:	  green	  –	  gut,	  purple	  –	  oral,	  yellow	  –	  skin);	  
and	   semivariograms	   to	   assess	   temporal	   correlation	   of	   observations	   in	   the	   stool	   samples	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Table	  1.	  Different	  types	  of	  analytical	  tools	  for	  microbial	  diversity	  analysis.	  This	  table	  highlights	  
different	   options	   researchers	   have	   for	   performing	  microbial	   diversity	   analyses.	  Developers	   of	  
new	   analytical	   tools	   should	   take	   advantage	   of	   existing	   options,	   and,	   especially,	   of	   pipeline	  
integration	  to	  avoid	  duplication	  of	  effort	  
	  
A	   more	   recent	   approach	   has	   been	   to	   develop	   pipelines	   that	   provide	   complete	   analysis	  
solutions,	   combining	   many	   steps.	   For	   example,	   if	   a	   researcher	   is	   interested	   in	   analyzing	  
microbial	   community	   data	   generated	   via	   high-­‐throughput	   amplicon	   sequencing	  data	   (such	   as	  
SSU	   rRNA),	   starting	  with	   files	   containing	   a	   hundred	  million	   sequences	   to	   a	   set	   of	  meaningful	  
statistics	  and	  visualizations,	  one	  tactic	  is	  to	  create	  a	  single	  workflow	  solution	  like	  mothur	  (15),	  
which	  provides	  one	  program	  for	  analysis	  (for	  a	  use	  case	  see	  (16));	  an	  inherent	  downside	  of	  this	  
approach	  is	  increased	  development	  time	  and	  support	  burden	  for	  a	  larger	  codebase,	  and	  errors	  
arising	   from	   reimplementation	   of	   each	   specialized	   analysis	   step	   into	   a	   single	   tool.	   Another	  
strategy	   is	   to	   wrap	   the	   original	   different	   applications	   in	   one	   single	   package;	   for	   example,	  
Quantitative	   Insights	   Into	  Microbial	   Ecology	   (QIIME)	   (17)	   provides	  workflows	   by	   splitting	   the	  
 6 
steps	  into	  fully	  transparent	  scripts	  (for	  a	  use	  case	  see	  (7));	  the	  cost	  is	  that	  the	  user	  must	  track	  
down	   and	   install	   the	   individual	   tools,	   but	   the	   user	   has	   substantially	   more	   control	   over	   the	  
analysis	   and	   knows	   that	   they	   are	   using	   ‘name-­‐brand’	   software.	   Another	   solution	   is	   to	   create	  
analytical	   web	   servers,	   such	   as	   Visualization	   and	   Analysis	   of	  Microbial	   Population	   Structures	  
(VAMPS)	   (18),	   which	   allows	   researchers	   to	   upload	   their	   16S	   rRNA	   data	   for	   analysis	   and	  
visualization	   (for	   a	   use	   case	   see	   (19)),	   or	   the	  Metagenomics	   RAST	   (MG-­‐RAST)	   server	   (20)	   for	  
studies	   based	   on	   shotgun	   metagenomic	   sequence.	   Although,	   web	   servers	   usually	   limit	   the	  
control	  that	  users	  have	  over	  their	  analyses,	  some	  analysis	  steps	  and	  methods	  are	  hidden	  when	  
source	  code	  is	  not	  available,	  and	  the	  user	  must	  fully	  commit	  to	  these	  tools	  rather	  than	  inserting	  
data	  at	  later	  stages	  or	  retrieving	  partial	  results,	  these	  tools	  provide	  a	  cost	  free	  analytical	  service	  
for	   researchers.	   A	   recent	   comparison	   of	   pipelines	   for	   metagenomic	   annotation	   and	   analysis	  
pipelines	   can	   be	   found	   in	   the	   supplementary	  material	   of	   SmashCommunity	   (21),	  which	   is	   an	  
open-­‐source,	   local	   solution	   to	   some	   of	   these	   problems;	   see	   Table	   1.	   Open	   source	   software,	  
where	  the	  source	  code	  is	  available	  for	  download,	  is	  critical	  for	  research	  software	  in	  general	  as	  
investigators	  can	  then	  check	  the	  correctness	  of	  the	  algorithms	  and	  make	  improvements.	  
The	  newest	  approach	  is	  to	  use	  virtual	  instances,	  either	  by	  virtualizing	  in	  a	  single	  computer	  (e.g.	  
VirtualBox	   (https://www.virtualbox.org/)	   or	   VMWare	   (http://www.vmware.com/)),	   where	  
resources	   are	   shared	   within	   a	   local	   machine	   (which	   can	   be	   a	   processing	   bottleneck),	   or	  
virtualizing	   in	   the	   ‘cloud’	   (e.g.	   EC2	   (http://aws.amazon.com/ec2)	   or	   Magellan	  
(http://magellan.alcf.anl.gov)),	   where	   external	   resources	   are	   used,	   sometimes	   at	   cost.	   Both	  
virtualization	   scenarios	   provide	   an	   environment	   to	   run	   virtual	   machines	   with	   preloaded	  
operating	   systems	   and	   programs.	   For	   example,	   CLoVR	   (22)	   can	   run	   several	   metagenomic	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analysis	  pipelines,	  and	  parallelizes	  some	  of	  these	  steps	  across	  virtual	  machines	  to	  speed	  up	  the	  
analysis.	   Similarly,	  Galaxy	   (http://galaxy.psu.edu/)	  provides	  a	  web	   interface	   to	   create	  analysis	  
pipelines,	  share	  them,	  and	  share	  data	  and	  results;	  see	  Table	  1.	  Both	  resources	  are	  open	  source.	  
The	  QIIME	  pipeline	   in	  particular	  exemplifies	   several	  key	  software	  engineering	  methodologies.	  
First,	  it	  is	  developed	  using	  agile	  software	  development	  techniques	  (23),	  which	  require	  constant	  
interaction	   with	   end-­‐users,	   rapid	   iterative	   development	   and	   updates,	   simplicity	   of	  
implementations	  and	  interfaces,	  etc.	  QIIME	  also	  relies	  heavily	  on	  test-­‐driven	  development	  (24),	  
which	   is	   similar	   to	   the	   concept	  of	  positive	  and	  negative	   controls	   in	   lab	   research	  and	   reduces	  
errors	   considerably.	   Furthermore,	   it	   is	   open	   source	   and	  distributes	   its	   software	  dependences	  
for	   a	   range	   of	   computational	   options,	   such	   as	   direct	   personal	   computer	   installation,	   virtual	  
machines	   images	   for	   single	   computer	   access	   via	   VirtualBox,	   and	   powerful	   cloud	   computing	  
options	  such	  as	  EC2	  and	  Magellan.	  	  
Summarizing	  and	  understanding	  microbial	  diversity	  
	  
The	  democratization	  of	  sequencing	  technology	  allows	  researchers	  to	  sequence	   large	  numbers	  
of	   samples	   from	   diverse	   environments	   [(2)	   and	   (3)].	   Large-­‐scale	   collaborative	   projects	   have	  
taken	  advantage	  of	  this	  possibility.	  For	  example,	  the	  Human	  Microbiome	  Project	  (25)	  sampled	  
250	  individuals	  two	  to	  three	  times,	   in	  five	  main	  sites	  (the	  GI	  tract,	  the	  mouth,	  the	  vagina,	  the	  
skin,	  and	  the	  nasal	  cavity),	  and	  the	  Earth	  Microbiome	  Project	  (26)	  will	  sequence	  up	  to	  200	  000	  
diverse	   environmental	   samples.	   A	   new	   challenge	   generated	   by	   these	   types	   of	   projects	   is	   to	  
compare	  not	  only	  large	  numbers	  of	  sequences	  but	  also	  large	  numbers	  of	  samples,	  and	  to	  relate	  
the	   variation	   in	   these	   samples	   to	   key	   clinical	   or	   environmental	   parameters.	   Although,	   as	  
outlined	   above,	   many	   ways	   of	   examining	   the	   data	   can	   be	   valuable,	   we	   focus	   here	   on	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dimensionality	  reduction,	  an	  especially	  useful	  technique	  for	  examining	  these	  multidimensional	  
matrices	   that	  have	  more	   variables	   than	   samples.	  Dimensionality	   reduction	  often	   yields	   easily	  
interpretable	  results,	  while	  reducing	  computational	  costs,	  relative	  to	  trying	  to	  understand	  large	  
taxon	  tables	  [(27)	  and	  (28)].	  
Dimensionality	   reduction	   techniques	   help	   us	   simplify	   data	   represented	   by	   a	   large	   number	   of	  
features	  compared	  to	  the	  number	  of	  samples	  [(27)	  and	  (28)].	  There	  are	  two	  general	  strategies:	  
feature	  transformation,	  which	  calculates	  a	  lower	  dimension	  projection	  of	  the	  original	  features	  
while	   retaining	   as	  much	   information	   as	   possible,	   and	   feature	   selection,	  which	  minimizes	   the	  
number	  of	   variables	   by	   locating	   the	   ‘best’	  minimum	   subset	   of	   the	  original	   features	   (27).	   The	  
two	   strategies	   can	   also	   be	   combined	   (29).	   In	   general,	   feature	   transformation	  has	   been	  more	  
widely	   applied	   in	   microbial	   ecology,	   even	   though	   the	   transformed	   features	   may	   have	   no	  
biological	   meaning	   [(29)	   and	   (30)];	   feature	   selection	   has	   primarily	   been	   applied,	   often	  
informally,	   in	   source	   tracking	   and	   biomarkers	   [(31)	   and	   (32)].	   Feature	   transformation	   can	   be	  
performed	  using	  unsupervised	  methods	  (that	  use	  only	  the	  data	  matrix	   itself),	   including	  metric	  
and	  non-­‐metric	  multidimensional	  scaling	  (MDS/NMDS),	  or	  by	  supervised	  approaches	  (that	  use	  
information	   about	   the	   samples,	   e.g.	   clinical	   or	   environmental	   categories)	   such	   as	   Linear	  
Discriminant	   Analysis	   (LDA)	   [(27)	   and	   (33)];	   see	   Table	   2.	   Both	   supervised	   and	   unsupervised	  
techniques	  are	  susceptible	   to	  noise	   in	   the	  category	   labels,	   for	  example,	  due	  to	  mislabeling	  of	  
samples	  or	  contamination.	  As	   these	   issues	  are	  a	   fact	  of	   life	   in	  projects	  covering	   thousands	  of	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  data	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  which	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  processing	  
time.	  Horseshoe	  effect.	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  and	  
metagenome	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Allows	  visualization	  of	  
high	  dimensional	  data	  
using	  lower	  
dimensions	  allowing	  
the	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  of	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  time	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  differences	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  with	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  effect.	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  plots	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  soil	  and	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that	  relies	  on	  a	  
mapping	  technique	  
that	  makes	  linear	  the	  
processing	  time	  
As	  this	  is	  an	  
approximation,	  it	  might	  
miss	  interesting	  
biological	  patterns	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  been	  used	  in	  other	  





that	  expands	  FastMap	  
to	  work	  on	  many	  
projections	  at	  once.	  
As	  this	  is	  an	  
approximation	  it	  might	  
miss	  interesting	  
biological	  patterns	  
Has	  been	  used	  in	  other	  





that	  uses	  a	  small	  
number	  of	  landmark	  
points	  to	  derive	  new	  
coordinates.	  
As	  this	  is	  an	  
approximation,	  it	  might	  
miss	  interesting	  
biological	  patterns	  
Has	  been	  used	  in	  other	  
research	  areas	  but	  not	  for	  
microbial	  community	  
comparisons	  
Table	  2.	  Different	  unsupervised	  feature	  transformation	  techniques	  and	  their	  biological	  findings.	  
This	  table	  summarizes	  some	  of	  the	  unsupervised	  feature	  transformation	  techniques	  and	  some	  
relevant	  biological	  findings	  achieved	  by	  the	  methods.	  It	  also	  shows	  other	  methods	  that	  need	  
some	  future	  research	  to	  assess	  their	  performance	  while	  comparing	  microbial	  communities	  
	  
One	  of	   the	  most	   commonly	  used	  dimensionality	   reduction	   techniques	   in	  microbial	   ecology	   is	  
principal	  coordinate	  analysis,	  PCoA,	  also	  known	  as	  MDS.	  PCA,	  or	  principal	  component	  analysis,	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is	  a	  special	  case	  of	  PCoA	  using	  Euclidean	  distance	  as	  a	  dissimilarity	  measure	  (35).	  PCoA	  takes	  as	  
input	  an	  n	  ×	  n	  matrix	  of	  distances,	  generally	  the	  results	  of	  beta	  diversity	  comparisons	  between	  
n	  samples	  in	  p-­‐dimensional	  space	  (traits)	  although	  phylogenetic	  distances	  such	  as	  UniFrac	  (36)	  
can	  also	  be	  used.	  It	  produces	  a	  k-­‐dimensional,	  k	  ≤	  p,	  representation	  of	  the	  items	  such	  that	  the	  
distances	  among	  the	  points	  in	  the	  new	  space	  preserve	  as	  closely	  as	  possible	  the	  distances	  in	  the	  
original	  data	  (28).	  In	  other	  words,	  points	  that	  are	  close	  in	  the	  original	  space	  are	  also	  close	  in	  the	  
new	   space.	   Results	   of	   MDS	   are	   indeterminate	   with	   respect	   to	   translation,	   rotation,	   and	  
reflection;	  in	  other	  words,	  the	  direction	  of	  each	  axis	  is	  arbitrary,	  although	  typically	  the	  axes	  are	  
chosen	  to	  maximize	   the	  variation	   in	   the	  data.	  PCoA	  can	  be	  used	  with	  any	  dissimilarity	  metric	  
(beta	   diversity):	   for	   current	   best	   practices	   for	   non-­‐phylogenetic	   metrics	   see	   (30),	   and	   for	  
phylogenetic	  metrics	  see	  (37).	  
PCA	   and	  PCoA	   rely	   on	   solving	   the	   eigenvalue	   equation	   to	   find	   a	   linear	   representation	  of	   our	  
samples	   by	   combining	   the	   original	   variables	   to	   generate	   the	   resulting	   k-­‐dimensional	  
representation	  of	  the	  data	  (35).	  Another	  approach	  that	  can	  reduce	  certain	  artifacts,	  such	  as	  the	  
horseshoe	  effect	  (a	  pattern	  in	  which	  the	  two	  ends	  of	  an	  axis	  attract	  each	  other	  due	  to	  a	  shared	  
lack	  of	  the	  taxa	  in	  the	  middle,	  thus	  obscuring	  the	  gradient	  pattern),	  is	  to	  use	  nonlinear	  methods	  
(38).	  NMDS	  can	  better	  preserve	   the	  high-­‐dimensional	   structure	  with	   few	  axes	   in	   some	  cases,	  
although	   cannot	   fully	   avoid	   the	   arch	   effect	   in	   realistic	   microbial	   datasets	   (30).	   The	   main	  
differences	  between	  PCoA	  and	  NMDS	  are	  that	  the	  former	  is	  based	  on	  distances,	  where	  the	  final	  
configuration	  should	  match	  the	  original	  distances	  as	  close	  as	  possible,	  and	  the	  latter	  is	  based	  on	  
ranks,	  which	   is	   robust	   to	   distribution	   effects,	   similar	   to	   the	   difference	   between	   Pearson	   and	  
Spearman	   correlations	   (39).	   One	   drawback	   to	  MDS	   is	   that	   it	   is	   not	   based	   on	   an	   eigenvalue	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solution	   but	   on	   numerical	   optimization:	   for	   larger	   datasets,	   the	   calculations	   become	   time-­‐
consuming;	  see	  Table	  2.	  
Because	  even	  PCoA	  is	  slow	  on	  large	  datasets,	  integrating	  new	  samples	  rapidly	  into	  large	  existing	  
datasets	  poses	  a	  major	  algorithmic	  challenge.	  Such	  techniques	  are	  critical	  for	  integrating	  results	  
from	   new	   studies,	   for	   example,	   new	   environments	   or	   patient	   populations,	   into	   large-­‐scale	  
datasets	  such	  as	  those	  provided	  by	  the	  Human	  Microbiome	  Project	   (25)	  or	  Earth	  Microbiome	  
Project	   (26).	   There	  has	  been	   substantial	   recent	   improvement	   in	   the	  performance	  of	   some	  of	  
these	   approximate	   algorithms	   for	   PCoA.	   For	   example,	   Nystrom	   techniques	   such	   as	   FastMap,	  
which	   uses	   a	   mapping	   technique	   to	   derive	   the	   k-­‐dimension	   representation,	   are	   linear-­‐time	  
algorithms	  rather	  than	  quadratic	  like	  PCoA	  (i.e.	  the	  time	  increases	  in	  proportion	  to	  the	  number	  
of	   samples	   rather	   than	   to	   the	   square	   of	   the	   number	   of	   samples)	   (40).	   MetricMap	   expands	  
FastMap	  to	  assess	  many	  projections	  at	  once,	  whereas	  FastMap	  calculates	  one	  dimension	  at	  the	  
time	   (41).	   Landmark	  MDS	   (LMDS)	   uses	   a	   small	   number	   landmark	   points,	   either	  manually	   or	  
randomly	  selected,	  to	  derive	  new	  coordinates	  (42);	  see	  Table	  2.	  For	  a	  performance	  comparison	  
of	  these	  methods	  see	  (43).	  The	  accuracy	  of	  these	  techniques	  have	  been	  assessed	  by	  methods	  
that	  determine	  how	  much	  of	  the	  variance	  is	  explained	  by	  the	  new	  set	  of	  axes	  (R2)	  or	  how	  much	  
the	  distances	  change	  in	  the	  low-­‐dimensional	  projection	  (Kruskal	  stress).	  The	  inherent	  problem	  
of	   these	   methods	   for	   determining	   accuracy,	   however,	   is	   that	   they	   do	   not	   relate	   well	   to	  
clustering	   quality	   or	   ability	   to	   interpret	   the	   patterns	   in	   the	   data	   (as	   has	   been	   previously	  
observed	   for	   different	  distance	  metrics,	  where	   the	  metric	   that	   explains	  most	  of	   the	   variance	  
may	   produce	   results	   that	   have	   no	   biological	   meaning	   (30)).	   Thus	   improved,	   and	   biologically	  




We	  are	  currently	  faced	  with	  daunting	  bioinformatics	  and	  computational	  challenges	  because	  of	  
the	  large	  numbers	  of	  sequences	  and	  samples	  now	  examined	  in	  microbial	  ecology	  studies,	  which	  
require	   the	   use	   of	   defined	   software	   engineering	  methods	   to	   create	   pipelines	   that	   are	   user-­‐
driven	   and	   well-­‐tested.	   Although	   these	   pipelines	   integrate	   many	   different	   techniques	   for	  
visualizing	   and	   understanding	   data,	   dimensionality	   reduction	   techniques	   such	   as	   PCoA	   have	  
proven	  especially	  valuable	  for	  understanding	  patterns	   in	  the	  data.	  However,	  these	  techniques	  
are	  reaching	  their	  limits	  as	  very	  large	  numbers	  of	  samples	  are	  analyzed	  in	  large-­‐scale,	  and	  on-­‐
going	   studies	   could	   potentially	   reach	   a	   processing	   bottleneck	   as	   these	  methods	   do	   not	   scale	  
linearly	  to	  the	  number	  of	  samples;	  approximate	  algorithms,	  which	  can	  be	  much	  faster,	  provide	  
a	  way	  out	  of	  this	  conundrum,	  but	  could	  also	  create	  a	  complication	  if	  research	  do	  not	  focus	  on	  
exact	  approximations.	  Thus,	  substantial	  additional	  work	  will	  be	  required	  in	  order	  to	  realize	  the	  
dream	  of	  rapid	  integration	  of	  new	  samples	  into	  large	  existing	  frameworks	  that	  cover	  our	  bodies	  
or	  our	  planet.	  
	  
In	  the	  next	  chapter	   I	  will	  discuss	  how	  the	   increasing	  number	  of	  microbial	  community	  samples	  
has	  shifted	  this	   field	   from	  being	  a	  descriptive	  science	  to	  predictive	  model-­‐based	  analyses	  and	  




II. Characterizing	  microbial	  communities	  through	  space	  and	  time	  
One	  outcome	  of	  the	  larger	  sampling	  efforts	  microbial	  ecology	  researchers	  are	  now	  undertaking	  
is	  the	  generation	  of	  more	  spatially	  and	  temporally	  aware	  datasets.	  These	  datasets	  will	  provide	  a	  
better	   understanding	   of	   the	   dynamics	   of	   the	   microbial	   communities.	   This	   opportunity	   also	  
represents	   a	   challenge	   as	   the	   field	   moves	   from	   a	   simple	   descriptive	   perspective,	   measuring	  
which	  kinds	  of	  microbes	  life	  together	  in	  each	  kind	  of	  environment,	  towards	  predictive	  modeling	  
methods,	   allowing	  us	   to	   improve	  our	   knowledge	  of	  how	   the	   communities	   change	   temporally	  
and	   spatially.	   	   This	   chapter	  was	   originally	   published	   in	   (44),	   and	   is	   the	   result	   of	  my	   in-­‐depth	  
conversations	  with	  expert	  microbiologists	  and	  microbial	  ecologist,	  and	  realizing	  the	  need	  for	  a	  
review	  of	   the	   current	  methods	   and	   algorithms	   to	   perform	   spatial	   and	   temporal	   analysis.	  My	  
responsibility	  as	  first	  author	  was	  to	  define	  the	  goals	  and	  expectations	  of	  this	  document,	  collate	  
the	   methods	   and	   write	   the	   overall	   document.	   Additionally,	   this	   helped	   me	   start	   the	  
biogeographical	  and	  temporal	  research	  group	  in	  the	  Knight	  lab.	  
	  
Introduction	  
Microorganisms	  are	  ultimately	  responsible	  for	  the	  health	  of	  all	  other	  organisms.	  Communities	  
of	   microbes	   decompose	   materials,	   recycle	   nutrients,	   break	   down	   pollutants,	   and	   aid	   in	   the	  
digestion	   of	   food	   in	   ‘higher’	   animals	  —	   they	   are	   the	   ‘ubiquitous	   janitors	   of	   the	   Earth’	   (45).	  
Microbes	   can	   also	   cause	   disease,	   destroy	   our	   food	   sources,	   and	   degrade	   our	   structures	   (as	  
reviewed	   in	   (45)).	   Early	   studies	   characterized	   a	   limited	   snapshot	   of	   microbial	   diversity.	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However,	  to	  predict	  or	  manipulate	  microbially	  mediated	  processes,	  we	  must	  understand	  spatial	  
and	  temporal	  patterns	  of	  diversity	  at	  multiple	  levels	  (Figure	  2).	  
	  
	  
Figure	  2.	  Improving	  our	  understanding	  of	  the	  variability	  of	  microbial	  communities.	  Spatial	  and	  
temporal	  studies	  ranging	  in	  scale	  from	  that	  of	  individual	  taxa	  to	  communities	  have	  allowed	  us	  
to	  detect	  patterns	  of	  distribution.	  However,	  in	  order	  to	  be	  able	  to	  fully	  understand	  the	  nature	  
and	  ranges	  of	  variability	  in	  microbial	  systems,	  research	  focusing	  on	  improving	  our	  ability	  to	  
predict	  whole	  communities	  across	  heterogenous	  space	  and	  time	  is	  much	  needed.	  Building	  upon	  
existing	  studies	  and	  tools	  of	  analysis	  will	  help	  us	  move	  from	  simply	  describing	  statistical	  
patterns	  to	  developing	  better	  predictive	  models.	  The	  accumulation	  of	  spatio-­‐temporal	  studies	  
for	  microbial	  communities	  across	  different	  ecosystems	  will	  provide	  essential	  information	  about	  
the	  expected	  scales	  of	  variability,	  allowing	  for	  better	  biological	  and	  ecological	  interpretations	  of	  
deviations	  from	  normal	  ranges	  of	  variability.	  
	  
Because	  of	   the	  astounding	  diversity	  of	  microbial	   communities	   (46),	   the	  ability	   to	  characterize	  
their	  fine-­‐scale	  temporal	  and	  spatial	  variation	  has	  only	  become	  achievable	  within	  the	  past	  five	  
years.	  Next-­‐generation	  ‘-­‐omics’	  technologies	  such	  as	  high-­‐throughput	  amplicon,	  metagenome,	  
and	  metatranscriptome	  sequencing	  [(47)	  and	  (48)]	  allow	  collection	  of	  thousands	  to	  millions	  of	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sequences	   at	   prices	   the	   average	   researcher	   can	   now	   afford.	   Recent	   research	   using	   next-­‐
generation	  technologies	  has	  focused	  on	  temporal	  and	  spatial	  associations	  [(49),	  (50),	  (51)	  and	  
(52)]	  of	  microbial	  communities,	  concentrating	  on	  clustering	  (e.g.,	  microbial	  communities	  from	  
different	   body	   habitats	   cluster	   separately	   (6))	   or	   correlations	   (e.g.,	   soil	   bacterial	   diversity	   is	  
correlated	   with	   pH	   (53)).	   However,	   unifying	   theories	   linking	   overall	   spatial	   and	   temporal	  
variation	   in	   microbial	   community	   structure	   to	   system	   functional	   processes	   have	   remained	  
elusive.	   Under	   similar	   environmental	   conditions,	   microbial	   communities	   can	   have	   strikingly	  
different	   composition	   and	   function	   [(54)	   and	   (55)];	   conversely,	   different	   community	  
configurations	  can	  function	  similarly	  [(5)	  and	  (56)].	  
Here,	   we	   discuss	   how	   community	   statistics	   from	   ecology	   can	   increase	   understanding	   of	  
microbial	   community	   structure–function	   relationships.	   This	   review	   covers	   recent	   advances	   in	  
molecular,	   culture-­‐independent	   studies,	   and	   highlights	   advances	   in	   statistical	   methods	   for	  
detecting	  and	  explaining	   spatially	   and/or	   temporally	  explicit	  patterns	   in	  microbial	   community	  
composition.	  We	  conclude	  that	  combined	  spatial	  and	  temporal	  studies	  that	  exploit	  inexpensive	  
DNA	   sequencing,	   together	   with	   improved	   bioinformatics	   tools	   and	   large-­‐scale	   automated	  
sampling	   techniques,	  will	   aid	   in	   understanding	   and	   predicting	   both	   the	   temporal	   and	   spatial	  
patterning	  of	  microbial	  communities,	  and	  the	  processes	  that	  underlie	  these	  patterns.	  
Foundations	  of	  modern	  microbial	  community	  ecology	  
Advances	   in	   sequencing	   technology	   and	   analytic	   tools	   to	   quantify	   differences	   between	  
communities	   have	   enabled	   the	   recent	   boom	   in	   microbial	   diversity	   studies.	   Limitations	   in	  
sequencing	   cost	   and	   coverage	   have	   largely	   been	   overcome	  with	   next	   generation	   sequencing	  
technologies	   that	  directly	   read	  single-­‐nucleotide	  additions	   to	  DNA	  strands	   (454	  and	   Illumina).	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Analytic	  obstacles	  due	  to	  issues	  of	  species	  identification	  were	  conceptually	  harder	  to	  overcome.	  
For	  example,	  the	  traditional	  definition	  of	  ‘species-­‐level’	  Operational	  Taxonomic	  Units	  (OTUs)	  at	  
97%,	  although	  useful	  for	  an	  overview	  of	  diversity,	  is	  problematic	  because	  it	  assumes	  that	  rates	  
of	   evolution	   and	   inherent	   genetic	   variation	   are	   equivalent	   across	   species,	   and	   excludes	  
phylogenetic	   information	   contained	   in	   sequence	   data	   [(57),	   (30)	   and	   (58)].	   Phylogenetic	  
community	  distance	  metrics	  such	  as	  UniFrac	  (59)	  reduce	  the	  impact	  of	  arbitrary	  OTU	  thresholds	  
and	   often	   provide	   better	   community	   clustering	   than	   taxon-­‐based	  methods,	   because	   even	   an	  
imperfect	   phylogenetic	   tree	   gives	   a	   far	   better	   picture	   of	   relationships	   among	  microbes	   than	  
does	   the	   ‘phylogeny’	   where	   all	   taxa	   are	   equally	   related	   implicitly	   assumed	   by	   taxon-­‐based	  
approaches	  (37).	  
Spatial	  studies	  of	  microbial	  diversity	  
Understanding	  how	  microbial	  communities	  vary	  at	  different	  spatial	  scales	  is	  important	  because	  
diversity	  hotspots	  and	  deserts	  can	  be	  identified,	  correlations	  with	  environmental	  factors	  can	  be	  
detected,	   and	   hypotheses	   about	   dispersal	   limitation	   or	   stochasticity	   of	   community	   assembly	  
can	   be	   tested.	   These	   issues	   of	   spatial	   scaling	   can	   be	   critical	   in	   downstream	   applications;	   for	  
example,	   it	   is	  essential	  to	  know	  the	  scale	  at	  which	  microbial	  diversity	  varies	  when	  designing	  a	  
bioprospecting	   sampling	   campaign	   to	  maximize	   the	  diversity	  of	   organisms	  or	   genes	   surveyed	  
[(60),	  (61)	  and	  (62)].	  
Central	   to	   the	   investigation	   of	   microbial	   spatial	   patterns	   is	   one	   of	   the	   most-­‐contested	  
hypothesis	   in	  microbial	  ecology:	   ‘everything	   is	  everywhere,	  but	  the	  environment	  selects’	   (63);	  
that	   is,	   local	  environmental	  conditions,	  or	   ‘filters’,	  select	  for	  community	  assemblages	  that	  can	  
best	   exploit	   or	   survive.	   Although	   several	   important	   environmental	   filters	   have	   been	   well-­‐
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studied	   (e.g.,	   [(59),	   (64),	   (65),	   (66)	   and	   (67)]),	   historical	   filters	   (i.e.,	   traces	   of	   past	   events	   or	  
community	   states)	   are	   also	   important	   in	   structuring	   communities	   [(68)	   and	   (69)].	   Thus,	   a	  
primary	  goal	  of	  spatial	  analysis	  techniques	  should	  be	  to	  measure	  the	  separate	  contribution	  of	  
history	  (e.g.,	  community	  assembly	  and	  patterns	  of	  microbial	  dormancy)	  and	  environment	  as	  a	  
function	   of	   the	   spatial	   configuration	   of	   the	   dataset.	   Ultimately,	   spatial	   pattern	   analysis	  
improves	   our	   ability	   to	   predict	   microbial	   diversity	   hotspots,	   and	   where	   microbes	   and	   their	  
associated	  functions	  are	  abundant	  in	  a	  given	  habitat.	  
Indeed,	  there	  are	  some	  strongly	  predictive	  patterns	  in	  spatial	  microbial	  diversity.	  For	  example,	  
taxa-­‐area	  analysis	  (regression	  of	  taxa	  observed	  vs.	  sampling	  area)	  has	  been	  adopted	  from	  island	  
biogeography	  (70).	  As	  with	  macroorganisms,	   larger	  areas	  harbor	  more	  microbial	   lineages,	  and	  
the	   taxa–area	   relationship	   has	   been	   referred	   to	   as	   one	   of	   the	   only	   ‘laws’	   of	   ecology	   (71).	   In	  
contrast,	  other	  spatial	  patterning	  of	  microbial	  alpha	  diversity	  deviates	  from	  patterns	  observed	  
for	   macroorganisms.	   For	   example,	   the	   well-­‐established	   pattern	   in	   macroorganisms	   that	  
diversity	  decreases	  with	  latitude	  seems	  to	  apply	  to	  marine	  (72)	  but	  not	  soil	  microbes	  (53),	  and	  
significant	   relationships	   between	   elevation	   and	   microbial	   diversity	   have	   not	   been	   observed	  
(73).	  
As	  noted	  above,	  phylogenetic	  beta	  diversity	  has	  been	  widely	  applied:	  it	  has	  been	  shown	  to	  vary	  
systematically	  at	  scales	  ranging	  from	  between	  continents	  [(58),	  (67)	  and	  (74)]	  to	  within	  a	  single	  
hand	  or	  computer	  keyboard	  (75).	  Whether	  communities	  of	  similar	  composition	  cluster	  together	  
in	   space	   can	   be	   detected	   using	   variograms,	   which	   graphically	   represent	   the	   relationship	  
between	  two	  distance	  matrices	  [(51)	  and	  (58)];	  the	  statistical	  significance	  of	  these	  associations	  
can	   explored	   with	   the	   Mantel	   test	   (76).	   These	   representations	   also	   allow	   researchers	   to	   fit	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models	  that	  explicitly	  determine	  the	  range	  of	  spatial	  autocorrelation	  (77)	  and	  produce	  input	  for	  
spatially	  explicit	  prediction	  algorithms,	  such	  as	  kriging	  or	  spatial-­‐partial	   regression	  (78),	  which	  
explain	  the	  overall	  patterns	  of	  variation	  and	  faithfully	  interpolate	  community	  structure	  at	  sites	  
not	  directly	  observed.	  
Although	   community-­‐level	  measurements	   and	   associations	   provide	   useful	   tools	   for	  microbial	  
biogeography,	  studies	  of	   individual	  taxa	  that	  are	  key	  players	   in	  an	  ecosystem	  are	  also	  critical:	  
for	  example,	  knowing	  that	  cyanobacteria	  are	  early	  colonizers	  because	  they	  fix	  nitrogen	  and	  act	  
as	  primary	  producers	  provides	  a	  level	  of	  insight	  that	  cannot	  be	  obtained	  purely	  from	  patterns	  of	  
similarity	  and	  difference	  at	  the	  whole	  community	  level.	  Recently	  employed	  methods	  that	  refine	  
overall	  spatial	  patterns	  in	  microbial	  communities	  include	  subdividing	  analyses	  by	  taxon	  (ranging	  
from	  species	  to	  phylum-­‐level),	  which	  can	  be	  used	  as	  inputs	  for	  niche	  modeling	  [(51)	  and	  (79)],	  
and	   using	   ordination	   techniques	   to	   identify	   indicator	   taxa	   (these	   include	   SAMOVA,	  DFA,	   and	  
SIMPER)	  (Table	  3).	  These	  methods	  allow	  the	  user	  to	  identify	  an	  individual	  clade	  or	  consortium,	  
and,	  when	  applied	  to	  metagenomic	  data,	  specific	  genes,	  that	  affect	  function	  (e.g.,	  the	  ability	  of	  
gut	   Bacteroidetes	   in	   Japanese	   people	   to	   degrade	   polysaccharides	   found	   in	   seaweed,	  
presumably	   horizontally	   transferred	   from	   marine	   Bacteroidetes	   consumed	   along	   with	   sushi	  
(80)).	   These	   newer	   methods	   share	   similar	   goals	   and	   often-­‐statistical	   methodologies,	   but	  
detailed	   comparisons	   on	   the	   same	   data	   have	   not	   yet	   been	   performed	   and	   there	   is	   not	   yet	  









when	  applied	  in	  spatial	  
studies	  
Information	  provided	  
when	  applied	  in	  
temporal	  studies	  
Spatial	  studies	   Correlative	   Variograms	   Indication	  of	  spatial	   Identification	  of	  the	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autocorrelation	   appropriate	  time	  scale	  
for	  sampling	  




An	  indication	  of	  how	  
many	  more	  taxa	  are	  
detected	  by	  sampling	  
larger	  areas	  (i.e.,	  taxa-­‐
area	  curves)	  
An	  indication	  of	  how	  
many	  more	  taxa	  are	  
detected	  by	  sampling	  
additional	  time	  points	  
Spatial	  studies	   Predictive	   Kriging	  
Interpolation	  of	  data	  at	  




Interpolation	  of	  data	  at	  








NA	  (or	  not	  yet	  
determined?)	  
Identification	  of	  cyclical	  









based	  on	  a	  metric	  of	  
similarity	  
Temporal	  structuring	  of	  
taxa/communities	  
based	  on	  a	  metric	  of	  
similarity	  




occurrence	  patterns	  of	  
taxa	  and/or	  communities	  
over	  space	  
Association	  or	  co-­‐
occurrence	  patterns	  of	  
taxa	  and/or	  
communities	  over	  time	  
Both	   Predictive	  
Niche	  
modeling	  
Prediction	  of	  expected	  
taxon/community	  
distributions	  in	  space,	  






over	  time,	  assessment	  
of	  niche	  conservation	  
Table	  3.	  Different	  types	  of	  spatial	  and	  temporal	  analysis,	  and	  their	  applications.	  This	  table	  
highlights	  the	  deep	  connections	  between	  spatial	  and	  temporal	  studies,	  and	  the	  frequent	  
applicability	  of	  techniques	  developed	  for	  one	  type	  of	  analysis	  to	  the	  other.	  Further	  spatial	  and	  
temporal	  sampling	  in	  projects	  such	  as	  the	  Earth	  Microbiome	  Project	  will	  likely	  highlight	  
additional	  deep	  connections.	  
	  
Temporal	  studies	  of	  microbial	  diversity	  
Like	   spatial	   studies,	   temporal	   studies	   can	   identify	   taxa	   shared	  at	  different	   times,	   correlations	  
with	   environmental	   conditions	   that	   affect	   the	   communities,	   and	   the	   relative	   contribution	   of	  
different	  processes,	  including	  stochastic	  processes	  and	  priority	  effects,	  to	  community	  structure	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[(56)	  and	  (82)].	  However,	  unlike	  spatial	  studies,	  temporal	  studies	  have	  provided	  greater	  insight	  
into	  processes.	  Recent	  studies	   in	  different	  environments	  have	  shown	  that	  some	  communities	  
exhibit	   cyclical	  patterns	   (66),	   others	  exhibit	   a	  monotonic	   trajectory	   (e.g.,	   the	  development	  of	  
the	  gut	  microbial	  community	  from	  the	  newborn	  to	  the	  adult	  (83)),	  and	  others	  remain	  relatively	  
stable	  over	   time	  (e.g.,	   the	  human	  mouth	  community	   (7),	  or	   the	  hypolimnion	  of	  stratified	  bog	  
lakes	  (84)).	  
Temporal	   studies	   are	   now	   moving	   beyond	   observing	   temporal	   patterns	   using	   ordination	   or	  
other	   visualizations	   of	   community	   associations.	   A	   growing	   toolbox	   of	   descriptive,	  
nonparametric	   statistics	   for	   temporal	   microbial	   dynamics	   exists.	   These	   techniques	   include	  
correlation	  networks	  and	  analysis	  of	  community	  rate	  of	  change	  over	  time,	  and	  can	  be	  used	  for	  
exploring	  temporal	  patterns,	  then	  relating	  these	  patterns	  to	  specific	  biotic	  or	  abiotic	  drivers.	  For	  
example,	   temporal	  associations	  between	  commonly	  occurring	  OTUs	   in	  aquatic	  microbial	   time	  
series	   have	   be	   uncovered	   using	   correlation-­‐based	   networks	   analyses,	   such	   as	   local	   similarity	  
analysis	   [(85),	   (86)	   and	   (87)].	   Specifically,	  different	  ecosystems	   sharing	  a	   regional	  or	   climactic	  
driver	   were	   shown	   to	   exhibit	   similar	   changes	   in	   their	  microbial	   communities	   (e.g.,	   [(85)	   and	  
(88)]).	   In	   addition,	   aquatic	   bacterial	   communities	   correlate	   far	   better	   with	   phytoplankton	  
communities	   than	   with	   physical	   and	   chemical	   properties	   of	   the	   system	   (89).	   There	   are	   also	  
nonparametric	  methods	  that	  specifically	  test	  for	  temporal	  structure	  such	  as	  cycles,	  trajectories,	  
and	   serial	   objects	   (e.g.,	   [(76)	   and	   (90)]).	   Finally,	   measuring	   rates	   of	   change	   in	   the	   whole	  
microbial	   community	   or	   in	   specific	   taxa	   over	   time	   allows	   comparisons	   of	   these	   rates	   across	  
ecosystems	  or	  experimental	  treatments	  (91).	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An	  extensive	   legacy	  of	  aquatic	   timeseries	  observations	  exists	  due	   to	   routine	   limnological	   and	  
marine	  sampling	  efforts,	  and	  timeseries	  are	  now	  becoming	  available	   in	  other	  systems	  such	  as	  
wastewater	   treatment	   (e.g.,	   [(92)	   and	   (93)]),	   host-­‐associated	   systems	   (7),	   and	   air	   (e.g.,	   (94)).	  
The	  accumulation	  of	  more	  of	  these	  rich	  time	  series	  datasets	  for	  microbial	  communities	  across	  
different	  ecosystems	  will	  likely	  provide	  essential	  the	  first	  baseline	  for	  the	  expected	  nature	  and	  
scale	   of	   variability	   in	   microorganisms.	   An	   added	   benefit	   will	   be	   improved	   detection	   of	  
responses	   to	   disturbance	   events	   in	  microbial	   communities	   outside	  of	   the	   expected	   variation,	  
such	  as	  those	  observed	  after	  episodic	  typhoon	  events	  in	  a	  subtropical	  lake	  (95)	  or	  in	  the	  human	  
gut	   after	   antibiotic	   treatment	   (96).	   Such	   studies	   of	   response	   to	   perturbation	   are	   critical	   for	  
developing	  an	  understanding	  of	  factors	  that	  lead	  to	  resilience	  in	  different	  communities,	  and	  for	  
predicting	  microbial	  responses	  to	  a	  changing	  planet.	  
Combining	  spatial	  and	  temporal	  studies	  of	  microbial	  communities	  towards	  predictive	  models	  
Combining	  spatial	  or	  temporal	  series	  can	  reveal	  key	  features	  of	  a	  system.	  For	  example	  Caporaso	  
et	  al.	   (7)	   combined	  both	   spatial	   and	   temporal	   components	   in	  a	  microbial	   study	   to	  assess	   the	  
variation	   of	   microbial	   communities	   of	   the	   human	   microbiome.	   The	   addition	   of	   extensive	  
temporal	   sampling	   to	  a	  previous	   study	   (6)	   led	   to	  a	  novel	  perspective:	  although	  each	  spatially	  
explicit	   location	  on	   the	  human	  body	   retains	   a	   compositional	   difference	   from	  other	   locations,	  
the	  communities	  within	  each	  location	  shift	  over	  time.	  That	  is,	  each	  location	  retains	  only	  a	  small	  
‘temporal	  core’	  of	  species-­‐level	  phylotypes	  within	  a	  community	  over	  time.	  
Analysis	  tools	  developed	  for	  spatial	  studies	  can	  sometimes	  be	  applied	  to	  temporal	  studies,	  or	  
vice	  versa.	  For	  example,	  in	  (97),	  variograms	  were	  used	  to	  identify	  the	  temporal	  scales	  at	  which	  
E.	   coli	   concentrations	   increased	  within	   a	  watershed.	   Similarly,	  wavelet	   analysis,	   a	  method	   to	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find	  the	  dominant	  periodic	  phenomena	  in	  a	  time	  series	  by	  decomposing	  those	  signals	  on	  a	  local	  
timescale,	   was	   used	   in	   an	   in	   vitro	   gut	   microbial	   community	   analysis	   which	   revealed	   the	  
strongest	   population	   cycles	   in	   Bacteroidetes	   and	   Firmicutes	   (98).	   Creative	   applications	   of	  
techniques	   developed	   for	   one	   type	   of	   study	   to	   others	   will	   likely	   yield	   additional	   benefits	   in	  
future,	   as	  will	  merging	   the	   two	   types	   of	   studies.	   For	   example,	   samples	   taken	   along	   a	   spatial	  
gradient	  that	  vary	  due	  to	  time,	  known	  as	  chronosequences,	  for	  example,	  ecosystem	  succession	  
(99),	   glacial	   recession	   (100),	   spoil	   heap	   development	   (101),	   inherently	   have	   both	   spatial	   and	  
temporal	   components.	  However,	   spatial	   patterning	   and	   temporal	   patterning	   are	   conflated	   in	  
such	   studies;	   techniques	   such	   as	   niche	   modeling	   could	   potentially	   assist	   in	   resolving	   these	  
issues.	   Similarly,	   studies	   that	   track	   timeseries	   at	  multiple	   sites	   or	   in	  multiple	   subjects	  will	   be	  
essential	   for	   understanding	   factors	   that	   affect	   community	   dynamics	   as	   well	   as	   structure.	  
Describing	   different	   resolutions	   of	   microbial	   community	   spatial	   variability,	   from	   microns	   to	  
continents,	  and	  temporal	  variability,	  from	  hours	  to	  decades,	  will	  inform	  prediction	  of	  dynamics	  
and	  responses	  to	  novel	  events.	  	  
Conclusion	  
Our	  review	  has	  described	  issues	  concerning	  the	  description	  of	  microbial	  communities	  and	  their	  
relevant	  impact	  on	  the	  systems	  in	  which	  they	  reside.	  We	  have	  also	  described	  the	  use	  of	  existing	  
and	  nascent	  analytical	  tools.	  In	  the	  past,	  studies	  of	  spatial	  and	  temporal	  dynamics	  of	  microbial	  
communities	  have	  been	  limited	  to	  descriptions,	  rather	  than	  predictive	  models	  [(51)	  and	  (62)].	  
The	   advent	   of	   high-­‐throughput	   multi-­‐omics	   tools	   and	   the	   decreasing	   cost	   of	   automated	  
sampling	   equipment	   enables	   adoption	   by	   the	   scientific	   community.	   Eventually,	   model-­‐based	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approaches	  will	  be	  a	  key	  goal	  of	  future	  studies	  of	  microbial	  communities,	  and	  will	  allow	  us	  to	  
test	  and	  appropriately	  apply	  what	  we	  think	  we	  have	  learned.	  
	  
In	   the	  next	   chapter	   I	  will	   discuss	   the	   importance	  of	  microbes	   in	  human	  health,	   specifically	   in	  
relation	   to	   behavior,	   and	   the	   importance	   of	   collecting	   and	   understanding	   even	   longer	   time	  
series.	  These	  studies	  should	  not	  only	  provide	  a	  better	  insight	  into	  the	  patterns	  of	  the	  microbial	  




III. The	  mind-­‐body-­‐microbial	  continuum	  	  
Our	  bodies	  are	  home	  to	  a	  huge	  number	  of	  microbes	  that	  provide	  novel	  metabolic	  functions	  that	  
the	  human	  body	   cannot	  provide	   from	   the	  human	  genome	  alone.	   These	  new	   functions	   shape	  
our	  health	  and	  wellbeing.	  This	  review,	  originally	  published	  in	  (102),	   is	  the	  result	  of	  my	  visit	  to	  
the	  germ-­‐free	  mouse	  facility	  of	  the	  Gordon	  Lab	   in	  Washington	  University	   in	  St.	  Louis,	  where	  I	  
saw	  a	  gnotobiotic	  mice	  “behave”	  strangely,	  jump	  in	  circles,	  together	  with	  my	  personal	  interest	  
of	   the	  role	  of	  different	   foods	  as	  migraine	  triggers.	  My	  role	  as	  main	  author	   included	   literature	  
research,	  interviews	  with	  people	  in	  charge	  of	  the	  germ-­‐free	  mouse	  facility,	  and	  coordinating	  the	  
other	  coauthors’	  contributions.	  
	  
Introduction	  
Advances	   in	   DNA	   sequencing	   technology	   have	   provided	   researchers	   with	   the	   exciting	  
opportunity	  to	  examine	  microbial	  diversity	  at	  different	  sites	  on	  the	  human	  body	  without	  having	  
to	  rely	  on	  cumbersome	  and	  oftentimes	  inadequate	  culture-­‐based	  methods	  (6).	  Our	  guts	  contain	  
tens	  of	  trillions	  of	  microbes,	  by	  far	  the	  largest	  collection	  among	  our	  various	  body	  habitats.	  The	  
gut	   ecosystem	   is	   dominated	   by	  members	   of	   one	   of	   three	   domains	   of	   life	   on	   earth,	   Bacteria,	  
although	   members	   of	   the	   other	   two	   known	   domains,	   Archaea	   and	   Eukarya,	   are	   also	  
represented,	   as	   are	   their	   viruses.	   Culture-­‐independent	   (“metagenomic”)	   studies	   have	   shown	  
that	  (i)	  early	  colonization	  of	  the	  body	  is	  affected	  by	  the	  mode	  of	  delivery	  (103);	  (ii)	  assembly	  of	  
the	  gut	  microbial	  community	  occurs	  over	  the	  course	  of	  the	  first	  3	  years	  of	  life	  (83);	  (iii)	  there	  is	  
pronounced	  interpersonal	  variation	  in	  the	  bacterial	  species	  composition	  of	  a	  given	  body	  habitat	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(6),(104);	   (iv)	  within	  an	   individual	  microbial	  community	  structure	  varies	  considerably	  between	  
body	  habitats	  (6);	  and	  (v)	  feces	  provide	  an	  excellent,	  safely	  obtained	  representative	  sample	  for	  
defining	  interpersonal	  differences	  in	  gut	  community	  ecology	  (104).	  
Twin	  studies	  have	  also	  provided	  important	  insights	  about	  the	  relative	  effects	  of	  genotype	  and	  
environment	   in	  shaping	   the	  structures	  of	  our	  microbial	  communities.	  Remarkably,	   the	  overall	  
degree	   of	   similarity	   of	   gut	   bacterial	   community	   composition	   is	   the	   same	   in	   adult	  mono-­‐	   and	  
dizygotic	   twin	   pairs	   (5).	   Moreover,	   members	   of	   the	   same	   family	   share	   a	   greater	   degree	   of	  
similarity	  in	  their	  gut	  bacterial	  community	  configurations	  than	  do	  those	  belonging	  to	  different	  
families	   (5).	  Each	   individual	  contains	  a	  distinct	  collection	  of	  gut	  bacterial	  species,	  even	   if	   they	  
are	  a	  member	  of	  a	  monozygotic	  twin	  pair	  (5),(105).	  While	  there	  does	  not	  appear	  to	  be	  a	  core	  
set	   of	   abundant	   bacterial	   species	   in	   a	   given	   body	   habitat	   that	   is	   shared	   among	   all	   humans,	  
(105),(106)	   there	   is	   a	   shared	   set	  of	  microbial	   genes,	   at	   least	   in	   the	   gut	   (5).	   Families	  not	  only	  
share	  this	  core	  microbiome	  but	  also	  have	  a	  greater	  degree	  of	  overall	  similarity	   in	  the	  variable	  
component	  when	  compared	  with	  unrelated	  individuals	  (5).	  
Together,	   these	   findings	   reveal	   a	   flow	   of	  microbes	   and	  microbial	   genes	   that	   occur	   between	  
members	  of	  a	  family	  and	  across	  generations	  within	  a	  kinship.	  This	  flow	  appears	  to	  be	  influenced	  
by	   early	   environmental	   exposures,	   as	   evidenced	  by	   the	   lack	   of	   a	   significant	   difference	   in	   the	  
overall	   degree	   of	   phylogenetic	   similarity	   of	   gut	   communities	   among	   mono-­‐	   compared	   with	  
dizygotic	   twin	   pairs.	   Early	   environmental	   exposures	   include	   physical	   contact	   among	   family	  
members,	  but	  also	  exposure	  to	  various	  diets,	  including	  mother's	  milk.	  As	  such,	  it	  is	  reasonable	  
to	   conclude	   that	   features	   of	   our	   human	   postnatal	   development,	   including	   central	   nervous	  
system	  (CNS)	  functions,	  are	  influenced	  by	  factors	  that	  also	  impact	  the	  assembly	  and	  operations	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of	   our	   microbial	   communities.	   The	   fact	   that	   intrapersonal	   variation	   in	   microbial	   community	  
composition	  within	  a	  body	  habitat	  is	  substantially	  less	  than	  interpersonal	  variation	  means	  that	  
each	   individual	   represents	   his	   or	   her	   own	   best	   control	   for	   assessing	   the	   effects	   of	   various	  
disturbances/perturbations	   (eg,	   dietary,	   pharmacologic)	   on	   microbiota/microbiome	   structure	  
and	   function,	   while	   family	   provides	   the	   “next	   best”	   reference	   controls.	   One	   of	   the	   striking	  
features	  of	  a	  variety	  of	  neuropsychiatric	  diseases	  (eg,	  affective	  disorders)	  is	  their	  variance,	  with	  
differences	   observed	   across	   individuals	   in	   terms	  of	   their	   susceptibility,	   in	   the	   combination	  of	  
systems	   that	   are	   disturbed,	   and	   in	   the	   therapeutic	   and	   adverse	   responses	   to	   various	  
medications.	  This	  article	  underscores	  the	  possibility	  that	  the	  microbiome	  represents	  a	  source	  of	  
this	  observed	  variance.	  
Microbial	  communities	  that	  affect	  behavior	  
The	  literature	  is	  replete	  with	  descriptions	  of	  the	  effects	  of	  infection	  with	  a	  variety	  of	  eukaryotic,	  
bacterial,	   and	   viral	   species	   on	   host	   behavior.	   An	   effect	   with	   a	   well-­‐understood	   evolutionary	  
basis	   is	   the	   interaction	   between	   Toxoplasma	   gondii	   -­‐	   the	   eukaryotic	   pathogen	   that	   causes	  
toxoplasmosis	  -­‐	  and	  its	  rodent	  host.	  T.	  gondii,	  like	  many	  parasites,	  has	  a	  complex	  lifestyle	  that	  is	  
partly	  completed	  in	  one	  host	  (rodent)	  and	  then	  in	  another	  host	  (feline);	  the	  rodent	  host	  loses	  
its	   innate	   fear	   of	   the	   smell	   of	   bobcat	   urine,	   and	   thus	   seeks	   out	   locations	   with	   that	   smell,	  
(107),(108)	   increasing	   its	   chances	   of	   being	   consumed	   and	   transmitted	   to	   the	   other	   host.	   T.	  
gondii	  has	  also	  been	  linked	  to	  behavioral	  effects	   in	  nontarget	  hosts,	   including	  humans,	  where	  
gender-­‐specific	  effects	  on	  personality	  traits	  including	  self-­‐control,	  warmth,	  and	  novelty	  seeking	  
(eg,	   tendency	  towards	  highrisk	  activities)	  have	  been	  observed	  (109),(110),(111).	  Many	  viruses	  
affect	   behavior;	   for	   example,	   bornavirus	   (has	   been	   related	   to	   mania	   and	   schizoaffective	  
 27 
disorders	  (112-­‐114);	  human	  immunodeficiency	  virus	  (linked	  to	  cognitive	   impairment,	  affective	  
disorders,	  and	  psychosis	  (115-­‐117)),	  rabies	  (a	  zoonotic	  infection	  caused	  by	  an	  enveloped	  single-­‐
stranded	  RNA	  virus	  that	  in	  its	  fulminant	  form	  is	  associated	  with	  hydrophobia	  (118)).	  The	  same	  is	  
true	  of	  bacteria;	  cognitive	  and	  emotional	  disturbances	  have	  been	  associated	  with	  Brucella	  suis	  
infection	   (119);	  manic	   and	  psychotic	   symptoms	   resistant	   to	   antipsychotics	   but	   treatable	  with	  
antibiotics	   during	   infection	  with	   Leptospira	   (120);	   baseline	   depression	   and	   anxiety	   caused	  by	  
Mycobacterium	   tuberculosis	   (121);	   and	   obsessive-­‐compulsive	   disorder	   (OCD)	   and	   pediatric	  
autoimmune	   neuropsychiatric	   disorders	   associated	   with	   streptococcal	   infections	   (PANDAS)	  
(122,	  123).	  
Poorly	   understood	   from	   a	   mechanistic	   perspective,	   but	   perhaps	   more	   intriguing,	   are	   cases	  
where	   an	  entire	  microbial	   community	   impacts	  host	   behavior.	   These	  effects	   have	  been	  noted	  
when	  comparing	  the	  phenotypes	  of	  mice	  reared	  from	  birth	  and	  from	  generation	  to	  generation	  
under	   sterile	   conditions	   in	   specialized	   gnotobiotic	   isolators	   that	   prevent	   any	   exposure	   to	  
environmental	   microbes	   (“germ-­‐free”	   animals)	   with	   mice	   that	   have	   been	   reared	   in	   the	  
presence	   of	   microbes	   but	   under	   specified	   pathogen-­‐free	   conditions	   (“conventionally	   raised”	  
animals),	  or	  mice	  that	  were	  reared	  germ-­‐free	  and	  then	  colonized	  at	  a	  given	  point	  in	  postnatal	  or	  
adult	   life	   with	   a	   microbiota	   transplanted	   from	   a	   conventionally	   raised	   donor	   (so	   called	  
“conventionalized”	   animals).	   For	   example,	   germ-­‐free	   mice	   exhibit	   basal	   behaviors	   in	   the	  
elevated	   plus	   maze	   (EPM)	   that	   are	   indicative	   of	   reduced	   anxiety	   levels	   (124).	   Using	   an	  
implantable	   detector	   of	   locomotion	   for	   quantitative	   phenotyping,	   Backhed	   et	   al	   (125)	   found	  
that	  germ-­‐free	  wild-­‐type	  (C57Bl/6J)	  mice	  have	  significantly	  increased	  movement	  compared	  with	  
their	   microbe-­‐laden	   counterparts,	   whether	   on	   a	   standard	   plant	   polysaccharide-­‐rich,	   low-­‐fat	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chow	   diet	   or	   a	   diet	   high	   in	   simple	   sugars	   and	   fat	   (Western	   diet).	   Conventionallyraised	  
genetically	   engineered	   mice	   lacking	   Toll-­‐like	   Receptor	   5	   (TLR5),	   a	   component	   of	   the	   innate	  
immune	   system	   that	   recognizes	   bacterial	   flagellin,	   have	   an	   altered	   gut	   microbiota,	   eat	  
substantially	  more	  than	  their	  conventionally-­‐raised	  wild-­‐type	  counterparts,	  and	  become	  obese.	  
The	   same	   phenotype	   can	   be	   transmitted	   to	   germfree	   wild-­‐type	  mice	   by	   transplanting	   a	   gut	  
microbiota	   from	  a	   conventionally-­‐raised	   TLR5	   knockout	   donor	   (126),	   suggesting	   that	   it	   is	   the	  
induced	  change	  in	  the	  microbiota	  that	  is	  changing	  the	  eating	  behavior.	  Fascinatingly,	  these	  mice	  
also	   develop	   metabolic	   syndrome,	   which	   is	   a	   frequent	   complication	   of	   the	   use	   of	   certain	  
psychotropic	   drugs.	   It	   is	   outside	   the	   scope	   of	   this	   review	   to	   cover	   the	   extensive	   literature	  
relating	   certain	   psychotropic	   drugs	   to	   the	   development	   of	   obesity	   and	  metabolic	   syndrome.	  
However,	  data	   from	  models	   such	  as	   the	  TLR5	  knockout	  mice	   indicate	   that	   there	   can	  be	   links	  
between	  the	  microbiota	  and	  metabolic	  syndrome	  (126),	  and	  we	  know	  that	  the	  microbiota	  can	  
have	   large	   effects	   on	   the	   metabolism	   of	   certain	   drugs	   (127).	   Therefore	   it	   is	   tempting	   to	  
speculate	  that	  the	  microbiota	  should	  be	  considered	  as	  a	  possible	  factor	   influencing	  metabolic	  
syndrome	   in	   response	   to	   psychotropic	   drugs	   in	   a	   subset	   of	   patients.	   In	   mice,	   microbial	  
communities	  also	  appear	   to	  be	   instrumental	   in	  generating	  scents	   (skin	  odor)	  and	  affect	  mate	  
preferences	  (128,	  129).	  This	  link	  between	  odor	  and	  mate	  preference	  has	  also	  been	  suggested,	  
but	   not	   established	   in	   humans	   (130),	   although	   the	   connection	   between	   bacteria	   and	   mate	  
choice	  has	  been	  established	  in	  fruit	  flies	  (131)	  and	  may	  therefore	  be	  widespread.	  
Diet,	  behavior,	  and	  the	  gut	  microbiota	  
There	   are	   numerous	   reports	   of	   diet	   affecting	   various	  manifestations	   of	   psychiatric	   disorders,	  
including	   schizophrenia,	   mono-­‐	   and	   bipolar	   depression	   (132),	   attention	   deficit	   -­‐hyperactivity	  
 29 
disorder	   (ADHD)	   (133,	   134),	   and	   autism	   (135,	   136),	   although	   the	   underlying	  mechanisms	   are	  
obscure	  and	  not	  all	  studies	  are	  adequately	  controlled.	  Diet	  has	  also	  been	  shown	  to	  play	  a	  key	  
role	   in	   shaping	   the	  structure	  and	   functional	  properties	  of	   the	  gut	  microbiota	   in	  both	  humans	  
(104,	  132)	  and	  in	  mice	  (127,	  137-­‐141).	  In	  considering	  the	  underlying	  mechanisms	  for	  how	  diet	  
affects	  behavior,	  the	  microbiota	  cannot	  be	  overlooked,	  because	  associations	  between	  diet	  and	  
psychiatric	   disorders	   are	   often	   thought	   to	   be	   related	   to	   metabolites	   of	   dietary	   components	  
(133,	  142,	  143).	  The	  enzymes	  that	  produced	  these	  metabolites	  may	  be	  encoded	  in	  our	  human	  
genome,	   or	   in	   the	   genomes	   of	   the	   microbes	   that	   inhabit	   our	   gut.	   The	   surprisingly	   high	  
compositional	   variation	   in	   gut	   bacteria	   across	   individuals	   (5)	   stands	   in	   stark	   contrast	   to	   the	  
surprisingly	   small	   amount	   of	   genetic	   diversity	   uncovered	   in	   the	   sequencing	   of	   our	   human	  
genomes.	   Differences	   in	   our	  microbial	   communities	  may	   thus	   be	   one	   of	   the	  most	   important	  
factors	   in	   differences	   in	   the	   metabolites	   that	   individuals	   extract	   from	   determining	   the	  
differences	  in	  the	  metabolites	  that	  different	  individuals	  may	  extract	  from	  similar	  diets.	  
Is	  the	  gut	  microbiome	  involved	  in	  autistic	  spectrum	  disorders?	  
DSM-­‐IV	   (and	   ICD-­‐10)	   classifies	   a	   number	   of	   disorders	   under	   the	   broad	   category	   pervasive	  
developmental	   disorder	   (PDD)	   or	   Autistic	   Spectrum	   Disorders	   (ASD)	   and	   include:	   autism	   or	  
autistic	   disorder	   (OMIM	   209850),	   Asperger	   syndrome	   (AS),	   Rett	   syndrome	   (RTT;	   OMIM	  
312750),	   childhood	   disintegrative	   disorder	   (CDD),	   and	   pervasive	   developmental	   disorder-­‐not	  
otherwise	   specified	   (PDD-­‐NOS)	   (144).	   The	   prevalence	   of	   the	   broader	   ASD	   phenotype	   can	  
approach	  ~0.5%	  in	  some	  populations	  (134).	  Depending	  upon	  the	  phenotyping	  method	  used	  and	  
disease	  severity,	  symptoms	  can	  be	  detected	  in	  very	  early	  childhood	  (145).	  Host	  genetic	  factors	  
appear	  to	  play	  a	  key	  role,	  with	  a	  large	  British	  study	  reporting	  a	  significantly	  higher	  concordance	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rate	  of	   certain	  phenotypic	   characteristics	   among	  monozygotic	   compared	  with	  dizygotic	   twins	  
(60%	   to	   92%	   versus	   0%	   to	   10%)	   (146).	   Genome-­‐wide	   association	   studies	   have	   revealed	   a	  
number	  of	   loci	   strongly	  associated	  with	  ASDs,	   including	   those	   involved	   in	  synaptogenesis	  and	  
synaptic	  function	  (eg,	  neurexins	  and	  the	  neuroligins	  that	  bind	  them	  (147,	  148)).	  
Although	   heritability	   in	   the	   British	   twin	   study	   was	   calculated	   to	   be	   >90%,	   environmental	  
influences	  may	  be	  still	  considerable.	  A	  “gut-­‐brain”	  linkage	  for	  ASDs	  has	  been	  proposed,	  based	  in	  
part	  on	  reports	  that	  children	  with	  ASDs	  often	  experience	  a	  range	  of	  gastrointestinal	  disorders	  
(149,	   150).	   A	   few	   reports	   indicate	   that	   children	  with	   ASDs	   have	   a	   greater	   representation	   of	  
members	  of	   the	  bacterial	   family	   Clostridiales	   (149-­‐151)	   in	   their	   fecal	  microbiota,	   although	  as	  
noted	   below,	   comprehensive	   analyses	   of	   gut	   microbial	   ecology	   in	   affected	   and	   reference	  
control	  populations	  have	  not	  yet	  appeared	  in	  the	  literature.	  
Microbial	  metabolism	  may	  have	  an	  impact	  on	  disease	  pathogenesis	  in	  ASD.	  Initial	  evidence	  for	  
this	   came	   from	   a	   small	   study	   of	   autistic	   children	   treated	   with	   the	   minimally	   absorbed	  
glycopeptide	   antibiotic	   vancomycin;	   short-­‐term	   improvement	   was	   reported	   (152),	   leading	   to	  
the	   suggestion	   that	   autistic	   symptoms	   may	   be	   related	   to	   the	   production	   of	   neurotoxic	  
metabolites	   by	   the	   gut	   microbiota.	   Two	   subsequent	   studies	   of	   metabolites	   in	   urine	   have	  
supported	  that	  microbial	  metabolism	  results	  in	  altered	  metabolite	  profiles	  in	  children	  with	  ASD.	  
The	  application	  of	  pattern	  recognition	  analysis	  to	  compare	  1H-­‐NMR	  spectra	  from	  the	  urine	  of	  
children	   with	   ASD	   to	   their	   relatives	   and	   age-­‐matched	   controls	   indicated	   that	   among	   the	  
metabolites	   that	   changed	   in	   concentration	   with	   autism	   were	   mammalian-­‐microbial	  
cometabolites,	   including	  dimethylamine,	  hippurate,	  and	  phenyacetylglutamine	   (142).	  Another	  
study	  showed	  that	  urinary	   levels	  of	  3-­‐(3-­‐hydroxyphenyl)-­‐3-­‐hydroxypropionic	  acid	   (HPHPA)	  are	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higher	  in	  children	  with	  autism	  compared	  with	  neurotypical	  controls	  (143).	  One	  potential	  source	  
of	  this	  compound	  is	  the	  conversion	  of	  phenylalanine	  from	  the	  diet	  to	  m-­‐tyrosine	  and	  then	  to	  3-­‐
hydroxyphenyl-­‐propionic	   acid	   by	   microbial	   enzymes,	   followed	   by	   conversion	   to	   HPHPA	   by	  
human	   enzymes	   (143).	   m-­‐Tyrosine	   induces	   a	   characteristic	   behavioral	   symptom	   in	   rats	   that	  
includes	   stereotypical	   behavior,	   hyperactivity,	   and	   hyper-­‐reactivity	   (153),	   indicating	   that	   this	  
compound	  may	   be	   specifically	   contributing	   towards	   autistic	   behaviors.	   A	  microbial	   origin	   for	  
HPHPA	  is	  supported	  by	  its	  decrease	  in	  urine	  after	  patients	  were	  treated	  for	  Clostridial	  infections	  
with	   metronidazole,	   an	   antibacterial	   agent	   with	   specificity	   toward	   anaerobic	   bacteria	   (143).	  
Some	   species	   within	   the	   Clostridiales	   are	   known	   to	   produce	   phenylpropionic	   acid	   and/or	  
monohydroxyphenylpropionic	  acid,	  which	  are	  very	  closely	  related	  biochemically	  to	  m-­‐tyrosine	  
and	  HPHPA	  (143).	  
A	  link	  between	  autism,	  gastrointestinal	  problems,	  and	  gut	  microbiota	  suggests	  that	  diet	  has	  the	  
potential	   to	   impact	   symptoms,	   and	  parents	   of	   autistic	   children	  have	   long	  been	  exploring	   the	  
impact	   of	   dietary	   and	   microbiota	   manipulations	   on	   behavior,	   for	   instance	   commonly	   using	  
gluten-­‐free	   and/or	   casein-­‐free	   (GF/CF)	   diets,	   probiotics,	   and	   nutritional	   supplements.	   Two	  
randomized	  controlled	  trials	  of	  the	  GF/CF	  diet	  indicated	  that	  it	  may	  improve	  symptoms	  in	  some	  
children	   (135,	   136),	   although	   these	   trials	   were	   small,	   both	   in	   terms	   of	   size	   and	   duration.	  
Although	  the	  GF/CF	  diet	  may	  improve	  symptoms	  by	  inducing	  changes	  in	  the	  microbiota	  and/or	  
their	  metabolites,	  another	  mechanism	  is	  by	  increasing	  gut	  integrity.	  Abnormally	  high	  intestinal	  
permeability	   (IPT),	   or	   a	   “leaky	   gut,”	   has	   also	   been	   associated	   with	   autism,	   suggesting	   that	  
autistic	   individuals	   may	   have	   increased	   sensitivity	   to	   components	   of	   our	   diet	   and	   their	  
metabolites,	  because	  they	  can	  more	  easily	  access	  the	  bloodstream	  (154).	  Autistic	  individuals	  on	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a	   GF/CF	   diet	   had	   significantly	   lower	   intestinal	   permeability	   compared	  with	   individuals	   on	   an	  
unrestricted	  diet	   (154).	  Genetic	   factors	  have	  also	  been	   implicated	   in	   impaired	  gut	   integrity	   in	  
autistic	  individuals;	  a	  mutation	  affecting	  the	  expression	  of	  the	  gene	  encoding	  the	  MET	  receptor	  
tyrosine	   kinase	   has	   been	   associated	   with	   both	   ASD	   and	   gastrointestinal	   conditions,	   and	  
functions	   in	   both	   brain	   development	   and	   gastrointestinal	   repair	   (155).	   To	   our	   knowledge	   no	  
study	  has	  evaluated	  how	  the	  GF/CF	  diet	  affects	  the	  structure,	  gene	  expression,	  and	  function	  of	  
the	  gut	  (fecal)	  microbiota	  or	  microbiome.	  
In	  general,	  studies	  of	  the	  gut	  microbiota	  in	  children	  with	  ASDs	  have	  been	  very	  limited,	  typically	  
examining	   just	  a	   few	  subjects,	  with	  shallow	  sequencing	  of	  bacterial	  16S	  rRNA	  gene	  amplicons	  
generated	  from	  just	  a	  few	  biospecimens/participant	  (ie,	  extensive	  time	  series	  studies	  have	  not	  
been	   performed),	   and	   without	   concomitant	   analyses	   of	   (i)	   microbiome	   gene	   content	   (by	  
shotgun	  sequencing	  of	  total	  fecal	  community	  DNA);	  (ii)	  microbiome	  gene	  expression	  (by	  RNA-­‐
Seq	  profiling	   of	   the	   community's	  meta-­‐transcriptome);	   or	   (iii)	  microbial	  metabolism	   (or	   host-­‐
microbial	   cometabolism,	   eg,	   by	  MS	   or	   NMR).	   Several	   groups	   are	   currently	   conducting	   these	  
types	   of	   analyses.	   The	   results	   may	   identify	   microbiota/microbiome	   biomarkers	   useful	   for	  
improved	   classification	   schemes,	   for	   understanding	   pathophysiology,	   and	   for	  monitoring	   the	  
efficacy	   of	   therapeutic	   interventions.	   With	   improved	   phenotyping	   (eg,	   using	   functional	  
magnetic	   resonance	   imaging	   [fMRI]	   or	   monitoring	   eyetracking)	   earlier	   diagnosis	   may	   be	  
possible,	   allowing	   for	   prospective	   characterizations	   of	   microbial	   community	   metabolism	   and	  
host-­‐microbial	  cometabolism	  during	  postnatal	  development	  (and	  in	  the	  mother).	  This	  emphasis	  
on	   the	  potential	   importance	  of	  microbial	  metabolism	   is	  based	   in	  part	  on	   the	  hypothesis	   that	  
neuroactive	  compounds	  produced	  by	  the	  gut	  microbiota	  may	  play	  an	  important	  role	  in	  shaping	  
 33 
synaptogenesis	   and	   synaptic	   function	   in	   the	   developing	   brain,	   especially	   in	   individuals	   with	  
genetic	  mutations	  affecting	  synaptic	  components	  or	  neurotransmitters	  that	  operate	  at	  various	  
types	  of	  synapses.	  
The	  gut	  microbiome	  and	  therapeutics	  
The	   gut	   microbiota	   has	   the	   capacity	   to	   process	   xenobiotics	   (compounds	   foreign	   to	   a	   living	  
organism),	  including	  over	  30	  known	  drugs	  administered	  to	  humans	  (156-­‐159),	  through	  a	  variety	  
of	   biotransformations	   including	   reduction,	   dehydroxylation,	   acetylation/deacetylation,	  
proteolysis,	  denitration,	  and	  hydrolysis	  (158).	  
One	  avenue	  for	  exploring	  the	  inter-­‐relationships	  between	  orally	  administered	  xenobiotics,	  the	  
human	   gut	   microbiome,	   and	   host	   metabolism	   is	   to	   use	   gnotobiotic	   animals	   colonized	   with	  
defined	  consortia	  of	  microbes	  from	  human	  or	  animal	  donors	  (160).	  A	  notable	  example	  was	  the	  
use	  of	  rats	  that	  were	  either	  germ-­‐free	  or	  colonized	  with	  a	  human	  fecal	  microbiota	  to	  investigate	  
the	   microbial	   production	   of	   equol,	   a	   metabolite	   with	   a	   proposed	   protective	   effect	   against	  
cancer,	   from	   a	   soy-­‐isoflavone	   containing	   diet	   (161).	   Humans	   vary	   in	   their	   ability	   to	   produce	  
equol	   from	   daidzein	   (a	   soy-­‐isoflavone).	   This	   metabolic	   phenotype	   is	   transmissible	   via	   the	  
microbiota,	  where	  germ-­‐free	   rats	   colonized	  with	   a	   fecal	   sample	   from	  a	  high	  equol-­‐producing	  
human	   donor	   excreted	   significant	   amounts	   of	   equol,	  while	   gnotobiotic	   rats	   colonized	  with	   a	  
fecal	  sample	  from	  a	  low	  equol-­‐producing	  donor	  had	  no	  detectable	  equol	  in	  their	  urine	  (161).	  
In	   addition	   to	   directly	   impacting	   the	  metabolism	   of	   xenobiotics,	   the	   gut	  microbiota	   can	   also	  
modify	  inactive	  drugs	  that	  have	  been	  conjugated	  and	  secreted	  in	  the	  bile.	  These	  reactions	  rely	  
on	  bacterial	  glucuronidases	  and	  sulfatases	  that	  have	  evolved	  to	  hydrolyze	  bile	  acids	  conjugated	  
to	   glycine	   or	   taurine	   (162).	   The	   resulting	   bacterial	   deconjugation	   allows	   the	   products	   to	   be	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reabsorbed.	   In	   some	   cases,	   this	  mechanism	   results	   in	   an	   extension	   of	   the	   half-­‐life	   of	   certain	  
drugs,	  including	  estrogens	  (163),	  digitoxin	  (158),	  indomethacin	  (164),	  and	  even	  morphine	  (158).	  
These	   observations	   raise	   the	   possibility	   of	   blocking	   microbial	   deconjugation	   through	  
combination	   therapy,	   to	   avoid	   recirculation.	   As	   an	   illustration	   of	   this	   concept,	  Wallace	   et	   al	  
(165)	  focused	  on	  CPT-­‐11	  (irinotecan),	  a	  chemotherapeutic	  drug	  currently	  in	  clinical	  use	  that	  has	  
a	  dose-­‐limiting	  side	  effect	  of	  severe	  diarrhea.	  The	  administered	  compound	  is	  a	  prodrug	  that	  is	  
processed	  in	  vivo	  to	  yield	  the	  active	  metabolite	  SN-­‐38	  (166).	  SN-­‐38	  is	  then	  glucuronidated	  in	  the	  
liver	   by	   uridine	   diphosphate	   (UDP)-­‐glurunosyltransf	   erase	   to	   form	   SN-­‐38G	   (167),	   which	   is	  
secreted	  through	  the	  bile	  into	  the	  small	  intestine.	  As	  with	  other	  compounds,	  this	  inactive	  form	  
is	   then	   reactivated	   by	   bacterial	   p-­‐glucuronidases	   (168),	   contributing	   to	   the	   development	   of	  
delayed-­‐onset	  diarrhea	  in	  40%	  of	  treated	  patients	  (169,	  170).	  
One	   approach	   to	   limit	   this	   bacterial	  metabolism	  would	   be	   to	   use	   broad-­‐spectrum	   antibiotics	  
(169).	   However,	   recent	   metagenomic	   studies	   have	   highlighted	   the	   long-­‐term	   effects	   that	  
antibiotic	   treatment	   can	  have	  on	   the	   commensal	  microbiota	   (96,	  170),	   potentially	   interfering	  
with	   hostmicrobial	   interactions	   that	   contribute	   to	   maintaining	   health	   or	   preventing	   disease.	  
Alternatively,	   if	   the	   bacterial	   enzymes	   of	   interest	   are	   known,	   as	   is	   the	   case	   for	   irinotecan	  
deconjugation,	  these	  enzymes	  can	  be	  targeted.	  To	  achieve	  this	  goal,	  E.	  coli	  b-­‐glucuronidase	  was	  
purified,	  its	  X	  ray	  structure	  determined	  (165),	  and	  used	  as	  the	  target	  or	  a	  chemical	  screen	  that	  
yielded	  an	  inhibitor	  of	  the	  bacterial	  (but	  not	  mammalian)	  enzyme.	  The	  lead	  compound	  was	  not	  
bactericidal	   for	   several	   members	   of	   the	   human	   gut	   microbiota	   in	   vitro,	   nor	   was	   it	   toxic	   to	  
mammalian	  cells.	  Moreover,	  surveys	  of	  groups	  of	  mice	  treated	  with	  CPT-­‐11	  alone,	  or	  with	  the	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enzymatic	   inhibitor	   alone,	   or	  with	   both	   the	   inhibitor	   and	   CPT-­‐11,	   revealed	   that	   combination	  
therapy	  greatly	  reduced	  symptoms	  (165).	  
These	   findings	   suggest	   that	   the	   gut	   microbiota	   is	   likely	   an	   important	   mediator	   of	   the	  
bioavailability	   and	   toxicity	   of	   some	   drugs.	   How	   much	   of	   the	   interpersonal	   variation	   in	  
pharmacokinetics	  is	  due	  to	  the	  microbial	  versus	  human	  component	  of	  our	  metagenomes?	  Does	  
diet	   impact	   drug	   metabolism	   via	   the	   gut	   microbiota?	   As	   in	   the	   case	   of	   irinotecan,	   can	  
combination	  therapies	  be	  developed	  that	  block	  or	  promote	  key	  microbial	  transformations?	  Can	  
differences	   in	   the	   metabolism	   of	   orally	   administered	   drugs	   be	   used	   as	   biomarkers	   for	  
differences	   in	   gut	   microbial	   metabolism	   that	   are	   relevant	   to	   the	   pathogenesis	   of	  
neuropsychiatric	   disorders?	   Although	   current	   lists	   of	   orally	   administered	   drugs	   known	   to	   be	  
subject	   to	   microbial	   modification	   is	   small,	   it	   seems	   prudent	   to	   explore	   this	   avenue	   when	  
considering	   psycho/neuroactive	   drugs	   that	   have	   narrow	   therapeutic	   indices,	   or	   various	  
idiosyncratic	  effects.	  
Conclusions	  
Our	  microbial	  communities	  both	  reflect	  and	  help	  define	  the	   interactions	  between	  our	  human	  
genotypes	   and	   our	  myriad	   environmental	   exposures.	   In	   the	   quest	   to	   understand	   the	   genetic	  
and	   environmental	   factors	   that	   shape	   the	   many	   facets	   of	   normal	   human	   behavior,	   the	  
variations	   in	  behavior	  that	  occur	  as	  we	  age,	  and	  the	  perturbations	   in	  our	  behavior	  associated	  
with	   various	   forms	   of	   mental	   disorders	   classified	   according	   to	   currently	   used	  
phenotypic/diagnostic	  parameters,	  it	  seems	  timely	  to	  incorporate	  studies	  of	  our	  microbiomes.	  
The	   challenge	   ahead	   is	   in	   large	   part	   “cultural.”	   Groups	   of	   clinician-­‐scientists	   with	   deep	  
understanding	   of	   higher	   brain	   function,	   including	   how	   to	   quantitatively	   phenotype	   these	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functions,	  must	  unite	  with	  those	  who	  study	  microbial	  ecology,	  familiarize	  each	  other	  with	  their	  
respective	  conceptual,	  experimental	  and	  computational	  tools,	  and	  then	  coevolve	  plans	  for	  well-­‐
controlled	  clinical	   studies.	  This	  effort	   requires	  crossing	   traditional	  disciplinary	  boundaries	  and	  
surmounting	   formidable	   language	   barriers.	   Moreover,	   since	   varying	   cultural	   traditions	  
(lifestyles)	   play	   an	   enormous	   role	   in	   shaping	   features	   of	   human	   behavior	   and	   our	   microbial	  
ecology,	  the	  “cultural”	  context	  in	  which	  these	  human	  studies	  are	  performed	  must	  be	  carefully	  
defined.	  Nonetheless,	   the	   stage	   for	   these	   interdisciplinary	   initiatives	   is	   in	  many	  ways	   already	  
set.	   For	   example,	   the	   National	   Institute	   of	   Health	   (NIH)'s	   Human	   Microbiome	   Connectome	  
Project	  is	  waiting	  to	  be	  “connected”	  to	  the	  NIH's	  Human	  Microbiome	  Project.	  
	  
In	  the	  next	  chapter,	  I	  will	  examine	  the	  latest	  temporal	  and	  spatial	  microbial	  community	  studies	  
from	   an	   ecological	   perspective.	   This	   new	   angle,	   together	   with	   the	   new	   analytical	   tools,	   as	  
discussed	  in	  chapter	  1,	  and	  the	  method-­‐prediction	  algorithms,	  as	  discussed	  in	  chapter	  2,	  could	  
lead	  us	  to	  realize	  the	  dream	  of	  controlling	  and	  predicting	  not	  only	  of	  the	  microbial	  communities	  
but	  also	  of	  the	  health	  of	  the	  host,	  as	  described	  in	  chapter	  3.	  This	  combination	  could	  also	  allow	  
researchers	   to	  make	  substantial	  progress	   towards	   the	  ultimate	  goal	  of	  personalized	  medicine	  
based	   on	   the	   microbiome.	   However,	   before	   these	   goals	   are	   feasible,	   we	   must	   first	   answer	  





IV. Our	  microbial	  selves:	  what	  ecology	  can	  teach	  us	  
With	  larger	  spatial	  and	  temporal	  studies,	  we	  can	  now	  begin	  to	  answer	  questions	  about	  bacterial	  
communities	   using	   well-­‐tested	   ecological	   theories.	   These	   new	   opportunities	   should	   lead	   us	  
towards	   an	  understanding	  of	   the	  daily	   changes	   in	   the	  microbiota	   even	  of	   healthy	   individuals	  
due	  to	  the	  environment	  and	  behavior	  of	  the	  host,	  and	  help	  us	  discern	  which	  changes	  might	  lead	  
towards	  a	  disease	   state.	  This	   chapter	  was	  originally	  published	   in	   (102),	   and	  was	   the	   result	  of	  
trying	  to	  understand	  ecological	  aspects	  that	  could	  affect	  microbial	  communities	  associated	  with	  
the	  human	  body,	  including	  dispersal,	  succession,	  and	  predator-­‐prey	  relationships.	  This	  interest	  
led	  me	  to	  assemble	  and	  lead	  a	  group	  of	  coauthors	  who	  could	  together	  attain	  a	  deep	  insight	  into	  
these	  ecological	  theories.	  
	  
Introduction	  
Microbial	   cells	   outnumber	   human	   host	   cells	   by	   up	   to	   one	   order	   of	   magnitude	   (171);	   it	   is	  
therefore	   unsurprising	   that	   these	   symbionts	   have	   an	   important	   role	   in	   human	   health.	   For	  
example,	   changes	   in	   the	   gut	   microbial	   community	   are	   linked	   to	   metabolic	   disorders	   (172),	  
obesity	   (5)	   and	   Crohn's	   disease	   (173).	   Efforts	   are	   under	   way	   to	   further	   understand	   and	  
characterize	  the	  human-­‐associated	  microbiota—the	  collection	  of	  microbes	  that	  inhabit	  us—and	  
its	   microbiome—the	   collection	   of	   genes	   in	   these	   organisms—through	   international	   projects	  
such	  as	  the	  Human	  Microbiome	  Project	  of	  the	  National	  Institutes	  of	  Health,	  the	  Metagenomics	  
of	   the	   Human	   Intestinal	   Tract	   initiative,	   and	   the	   European-­‐Union-­‐funded	   TORNADO	   project.	  
Most	   studies	   have	   focused	   so	   far	   on	   five	   areas	   of	   the	   body—the	   gut,	   skin,	  mouth,	   nose	   and	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vagina—with	   the	  goals	  of	  defining	  a	   core	  microbiome	  across	   individuals	  and	  determining	   the	  
relationship	   between	   the	   human	   microbiome	   and	   health	   and	   disease.	   Research	   on	   the	  
microbiome	   from	   a	   medical	   perspective	   has	   revealed	   the	   importance	   of	   human-­‐associated	  
microbial	   communities.	   However,	   viewing	   the	   human	   microbiome	   from	   an	   ecological	  
perspective	   can	   provide	   the	   biomedical	   community	   and	   microbiologists	   with	   a	   robust	  
framework	  for	  hypothesis	  testing	  (174-­‐176).	  
	  
Ecological	   studies	   provide	   an	   understanding	   of	   the	   way	   in	   which	   interactions	   with	   the	  
environment	   influence	   the	   distribution	   and	   abundance	   of	   species,	   populations	   and	  
communities	   over	   space	   and	   time.	   Community	   ecologists	   are	   interested	   in	   what	   controls	  
patterns	  in	  diversity	  and	  the	  dynamics	  of	  consortia	  in	  the	  same	  environment.	  As	  early	  as	  1914,	  
community	   ecologists	   sought	   to	   understand	   the	   distribution	   and	   abundance	   of	   coexisting	  
animal	  species,	  the	  spatial	  and	  temporal	  distribution	  of	  their	  communities	  and	  the	  interactions	  
among	   members	   of	   those	   communities	   (177).	   Applying	   ecological	   theory	   to	   microbial	  
communities	   has	   allowed	   the	   field	   to	   advance	   beyond	   basic	   descriptions	   and	   has	   allowed	  
microbial	  communities	  to	  become	  key	  model	  systems	  for	  testing	  ecological	  hypotheses,	  such	  as	  
neutral	   theory	   in	   community	   assembly	   (179-­‐181)	   and	   species–area	   relationships	   (51,	   178).	  
Further	  extensions	  of	  ecological	  theory	  from	  plants	  and	  animals	  to	  other	  microbial	  communities	  
will	  help	  us	  to	  understand	  our	  living	  world	  more	  comprehensively,	   including	  the	  ecosystem	  of	  
the	  human	  body	  (176).	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Here,	   we	   suggest	   a	   foundation	   in	   traditional	   ecological	   theory	   that	   will	   provide	   a	   deeper	  
understanding	   of	   the	   human	   microbiome,	   and	   ultimately	   facilitate	   the	   prediction	   of	  
microbiome	  dynamics	   in	  health	  and	  disease.	  We	   structure	   this	   review	  around	   four	  ecological	  
topics,	   showing	   the	  way	   that	  each	   could	  affect	  human	  microbiome	   research	  and	   focusing	  on	  
examples	   from	   the	   past	   five	   years	   in	   which	   data	   were	   collected	   by	   using	   high-­‐throughput	  
sequencing	   (Fig	   3).	   First,	   we	   discuss	   diversity	   and	   its	   implications	   for	   the	   distribution	   and	  
variability	  of	  human-­‐associated	  microbial	  communities.	  Second,	  we	  discuss	  biological	  drivers	  of	  
community	   structure,	   including	   interactions	   with	   invasive	   species,	   metacommunities,	   host	  
ecosystems	  and	  predators.	  Third,	  we	  consider	  spatial	  patterning.	  Fourth,	  we	  consider	  temporal	  
dynamics	   of	  microbial	   communities,	   highlighting	   implications	   for	   succession	   and	   response	   to	  
disturbances.	  We	  conclude	  by	  suggesting	  future	  applications	  of	  ecology	  to	  human	  microbiomes	  
that	  will	  aid	  in	  predicting	  responses	  to	  disturbances,	  and	  perhaps	  underpin	  new	  approaches	  to	  
personalized	  medicine—just	  as	  improved	  understanding	  of	  the	  ecology	  of	  macroorganisms	  has	  




Figure	   3.	   The	   human	   microbiome	   meets	   ecology.	   The	   human	   body	   can	   be	   visualized	   as	   an	  
ecosystem	   that	   is	   subject	   to	   the	   ecological	   processes	   that	   structure	   communities,	   including	  
dispersal,	   invasion,	   succession	  and	  meta-­‐community	  dynamics.	  At	   the	   local	   level,	   interactions	  
with	   members	   of	   the	   resident	   microbial	   and	   phage	   community,	   such	   as	   competition	   and	  
predation,	   probably	   shape	   the	   structure	   of	   the	   community,	   whereas	   the	   meta-­‐community	  
structure	  might	  be	  more	  influenced	  by	  interactions	  among	  communities,	  such	  as	  dispersal	  and	  
invasion,	   and	   stochastic	   events,	   such	   as	   disturbance.	   These	   types	   of	   interaction	   can	   extend	  
beyond	  the	  meta-­‐community	  to	  the	  ecosystem	  when	  more	  than	  one	   individual	   is	  considered,	  
and	   they	   can	   also	   vary	   temporally.	   Further	   studies	   of	   the	   human	   microbiome	   will	   help	   to	  
determine	   the	   effects	   of	   these	   processes	   on	   microbial	   interactions	   over	   space	   and	   time,	  
including	  intra-­‐	  and	  inter-­‐personal	  variation	  and	  development	  from	  birth,	  and	  ultimately	  lead	  to	  
a	  more-­‐comprehensive	  understanding	  of	  our	  microbial	  selves.	  
	  
Microbial	  Diversity	  
Throughout	   the	  history	  of	  microbiology,	   researchers	  have	  been	   interested	   in	  questions	  about	  
the	  abundance,	  distribution	  and	  interactions	  of	  organisms,	  as	  well	  as	  the	  ways	  in	  which	  these	  
relate	  to	  ecological	  processes	  (Fig	  4).	  From	  the	  first	  observation	  of	  dental	  microbes	  by	  Antonie	  
van	  Leeuwenhoek	  using	  the	  microscope,	  to	  the	  culturing	  and	  subsequent	  sequencing	  of	  specific	  
strains	  approximately	  300	  years	  later,	  technology	  has	  provided	  information	  about	  the	  presence,	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abundance	   and	   biology	   of	   our	   microscopic	   residents.	   Now,	   with	   the	   recent	   development	   of	  
high-­‐throughput	  sequencing	  and	  meta-­‐genomics,	  we	  are	  able	  to	  move	  from	  a	  purely	  descriptive	  




Figure	   4.	  New	   technologies	   reveal	   new	  pictures	   of	   human-­‐associated	  microbial	   communities.	  
With	   the	   development	   of	   new	   technologies—including	   but	   not	   limited	   to	   high-­‐throughput	  
sequencing—the	   increase	   in	   the	  amount	  of	  data	  we	  can	  gather	  has	  allowed	  us	   to	  better	   test	  
and	   understand	   the	   ecological	   processes	   acting	  within	   our	  microbial	   selves	   and,	   in	   turn,	  will	  
help	   to	   frame	   future	  work	  within	  an	  ecological	   context.	  The	  colour	  of	  each	  star	   indicates	   the	  
methodologies	   used	   in	   the	   different	   studies:	   dark	   blue,	   microscopic	   observation;	   blue,	  
culturing;	   green,	   Sanger	   sequencing;	   red,	   pyrosequencing;	   yellow,	   metagenome	   sequencing	  
(179-­‐181).	  Estimates	  are	  based	  on	  a	  rough	  count	  of	  individuals	  reported	  in	  studies	  and	  articles	  
describing	   human-­‐associated	  microbes	   or	   communities,	   and	   are	   probably	   underestimates	   of	  
the	  numbers	  of	  subjects.	  
	  
One	  method	  by	  which	  to	  address	  these	  questions	  is	  to	  measure	  and	  compare	  diversity	  metrics	  
for	   communities.	   Whittaker	   defined	   three	   measures	   to	   achieve	   this:	   (i)	   alpha	   diversity,	   to	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quantify	  the	  richness	  of	  the	  species—the	  number	  of	  taxa—in	  a	  niche	  (that	  is,	  which	  species	  are	  
found	   in	   a	   single	   habitat);	   (ii)	   beta	   diversity,	   to	   compare	   diversity	   between	   environments,	  
addressing	   the	  question	  of	  how	  different	  communities	  are	  structured	   in	  different	  niches;	  and	  
(iii)	   gamma	   diversity,	   which	   measures	   both	   alpha	   and	   beta	   diversity	   of	   communities	   from	  
different	  landscapes	  or	  geographical	  regions	  (182).	  A	  recurrent	  challenge	  in	  describing	  microbial	  
diversity	   is	   how	   to	   define	   the	   relevant	   species	   unit.	   For	   example,	   species	   diversity	   can	   be	  
measured	   by	   collapsing	   sequences	   into	   operational	   taxonomic	   units	   (OTUs)	   and	   functional	  
diversity	   by	   grouping	   sequences	   into	   codes	   in	   the	   enzyme-­‐commission	   (EC)	   hierarchy	   (183,	  
184).	  The	  resolution	  of	  such	  units	  can	  be	  specified	  by	  grouping	  the	  sequences	  at	  different	  levels	  
of	   identity,	   with	   higher	   identity	   defining	   more	   phylogenetically	   resolved	   biological	   groups—
strains	  compared	  with	  species,	  or	  protein	  families	  compared	  with	  superfamilies.	  
Understanding	   diversity	   is	   important	   because	   high	   species	   diversity	   can	   enhance	   ecosystem	  
function	   by	   buffering	   against	   invasion,	   increasing	   robustness	   to	   disturbances	   and	   facilitating	  
efficient	   use	   of	   resources	   (185,	   186).	   However,	   higher	   diversity	   does	   not	   always	   result	   in	  
enhanced	   function	   (187-­‐189).	  Diversity	  might	   also	  have	  a	   crucial	   role	   in	   ecosystem	  health	  by	  
contributing	   to	   stability	   (194,	   195).	   Diversity	  measurements	   have	   been	   used	   to	   infer	   general	  
patterns	  that	  are	  true	  for	  many	  taxa	  and	  ecosystem	  scales;	  perhaps	  the	  most	  famous	  example	  
is	   species–area	   curves	   (190),	  which	   consistently	   show	   that	   the	   alpha	   diversity	   of	   a	   habitat	   is	  
positively	  correlated	  with	  the	  size	  of	  the	  area	  being	  sampled	  (191).	  Large	  areas	  reduce	  the	  risk	  
of	  chance	  extinction	  and	  provide	  more	  niches	  than	  small	  areas	  (192).	  This	  relationship	  usually	  
fits	  a	  power-­‐law	  model,	  in	  which	  the	  number	  of	  species	  increases	  as	  a	  function	  of	  the	  size	  of	  the	  
sampled	   area.	   However,	   when	   comparing	   diversity	   across	   habitats,	   the	   opposite	   effect	   is	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generally	  observed:	  sampling	  a	   larger	  area	   increases	  the	  chance	  of	  observing	  species	  that	  are	  
shared	  among	  the	  habitats,	  reducing	  the	  number	  of	  unique	  species	  and,	  consequently,	  overall	  
beta	   diversity	   (182).	   Although	   these	   trends	   were	   inferred	   from	   the	   study	   of	   macroscopic	  
organisms	  (192),	  they	  might	  also	  be	  true	  for	  microbes	  (51,	  178).	  However,	  a	  detailed	  analysis	  of	  
species–area	   relationships	   in	   the	   human	  body	   has	   not	   yet	   been	   performed.	   For	   example,	   do	  
adults	  harbour	  a	  higher	  diversity	  of	  microbes	  than	  babies?	  Do	  molars	  harbour	  a	  higher	  diversity	  
than	  incisors?	  Furthermore,	  it	  is	  essential	  to	  establish	  the	  importance	  of	  high	  or	  low	  diversity	  in	  
the	  health	  of	  microbial	  communities	  from	  various	  human	  habitats,	  such	  as	  the	  gut	  or	  vagina.	  
Drivers	  of	  community	  structure	  
Biological	   interactions	   have	   a	   role	   in	   structuring	   communities.	   They	   can	   occur	   within	   a	  
community	  (such	  as	   interacting	  gut	  bacterial	  populations),	  across	  communities	  (gut	  compared	  
with	   oral	   microbiota),	   between	  microbiota	   and	   the	   host,	   and	   between	  microbiota	   and	   their	  
predators	   (such	  as	  bacteriophages).	  We	  select	  ecological	  examples	   relevant	   to	  understanding	  
the	   human	   microbiome,	   focusing	   on	   invasive	   species	   and	   models	   of	   interaction	   among	  
communities.	  
Community	   interactions:	  managing	   invasive	  microbes.	  An	   invasive	  species	   is	  a	  non-­‐indigenous	  
organism	   that	   spreads	   from	   the	   point	   of	   introduction	   and	   becomes	   abundant	   (193).	   This	  
includes	   both	   pathogenic	   and	   probiotic	   organisms	   that	   invade	   the	   human	   microbiota.	   The	  
invading	  organism	  must	  proliferate	  within	   the	  native	  community,	  distinguishing	   it	   from	  those	  
that	  merely	  survive	  in	  their	  new	  environment.	  Therefore,	  the	  success	  of	  the	  invader	  depends	  on	  
its	  interactions	  with	  the	  indigenous	  species.	  
 44 
Whether	  a	  non-­‐indigenous	  organism	  becomes	  invasive	  depends	  on	  both	  its	  ability	  to	  disperse	  
to	  a	  new	  location	  and	  the	  outcome	  of	  the	   interactions	  with	  both	  the	  new	  ecosystem	  and	  the	  
indigenous	   community	   (194),	   which	  might	   be	   affected	   by	   its	   relatedness	   to	   species	   that	   are	  
already	  present	  (195).	  Here,	  we	  focus	  on	  interactions	  with	  other	  species.	  Most	  immigrants	  fail	  
to	  establish	  themselves	  and	  will	  not	  become	  invasive	  (193).	  However,	  there	   is	  an	  opportunity	  
for	  success	   in	  a	  non-­‐native	  environment	   if	  a	  non-­‐indigenous	  species	  escapes	  native	  predators	  
that	   previously	   controlled	   population	   size,	   as	   stated	   by	   the	   enemy-­‐release	   hypothesis	   (196,	  
197).	   As	   a	   ‘predator’	   to	   foreign	   cells,	   the	   host	   immune	   system	  provides	   a	   connection	   to	   this	  
aspect	  of	   invasion.	  Successful	   invasive	  microbes	  might	  also	  escape	   from	  native	  viruses,	  which	  
are	  important	  in	  regulating	  bacterial	  populations	  ((198);	  see	  Interactions	  with	  predators).	  
A	  second	  opportunity	  for	  immigrant	  success	  occurs	  if	  the	  native	  community	  is	  recovering	  from	  a	  
disturbance	   or	   exists	   in	   an	   unstable	   disturbance	   regime.	   For	   gut-­‐associated	   microbiomes,	  
antibiotic	  disturbance	  or	  infections	  are	  known	  to	  alter	  gut	  communities	  (for	  examples	  see	  (170,	  
199));	   therefore,	   an	   immigrant	   might	   become	   invasive	   if	   the	   native	   community	   is	   stressed.	  
Finally,	  high	  numbers	  of	   immigrants	  or	  repeated	   immigration	  events	   increase	  the	  chance	  of	  a	  
successful	   invasion	   (200).	   For	  many	  probiotics,	   repeated	  exposure	   seems	   to	  be	   important	   for	  
maintaining	  the	  desired	  benefit,	  although	  there	  is	  conflicting	  evidence	  about	  their	  effectiveness	  
for	   relieving	   symptoms	  of	   irritable	  bowel	   syndrome	  or	   chronic	   irritable	  bowel	  diseases	   (201).	  
Questions	   about	   the	   ability	   of	   a	   species	   to	   invade	   are	   important	   given	   the	   interest	   in	   stool	  
transplantation,	  which	   seems	   to	   be	   an	   effective	   treatment	   for	   persistent,	   antibiotic-­‐resistant	  
Clostridium	  difficile	   infections	   (202).	   Fascinatingly,	   the	   intuitive	   idea	   that	   antibiotics	  will	   ease	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microbiota	  transfer	  by	  clearing	  out	  the	  original	  community	  does	  not	  seem	  to	  be	  true	  (203),	  and	  
additional	  work	  in	  this	  area	  will	  have	  important	  health	  implications.	  
For	   the	   indigenous	   community,	   invasion	   can	   alter	   community	   structure	   by	   reducing	   the	  
abundance	  of	  or	  eliminating	   species	   through	  competition	  or	  predation,	   as	  well	   as	  by	  altering	  
the	   habitat.	   For	   example,	   in	   patients	   with	   cystic	   fibrosis,	   invasion	   of	   the	   lungs	   by	   the	  
opportunistic	   pathogen	  Pseudomonas	   aeruginosa	   alters	   the	   biofilm	   environment	   by	   blocking	  
antimicrobials	   (204).	   The	   resulting	   environment	   is	   hidden	   from	   host	   immune-­‐system	  
phagocytes,	   also	   providing	   protection	   for	   less	   abundant	   non-­‐P.	   aeruginosa	   community	  
members.	  The	  cystic-­‐fibrosis	  microbiome	  has	  many	  other	  characteristics	  of	  the	  invasive-­‐species	  
framework.	   After	   colonization	   to	   a	   non-­‐native	   environment,	   species	   that	   become	   invasive	  
typically	   experience	   an	   indeterminate	   growth	   lag,	   often	   followed	   by	   natural	   selection	   for	  
mutants	   or	   phenotypes	   that	   are	   fitter	   in	   the	   new	   environment	   (200).	   These	   then	   rapidly	  
proliferate	  as	  the	  ‘successful’	  invading	  population.	  Given	  our	  understanding	  of	  invasion	  ecology	  
in	   other	   ecosystems,	   improved	   understanding	   of	   biotic	   interactions	   within	   the	   cystic-­‐fibrosis	  
lung	  communities	  could	  help	  us	  to	  control	  P.	  aeruginosa	  invasion	  by	  introducing	  other	  microbes	  
that	  block	   its	  establishment	   through	  production	  of	   the	   toxin	  Bacterocin	   (205),	  or	  by	  selecting	  
harmless	  strains	  to	  displace	  this	  pathogen.	  
Community	   interactions:	   one	   host,	   many	   microbiomes.	   Although	   microbial	   communities	   are	  
often	  defined	  by	   geographical	   barriers,	  microbes	  have	   remarkable	   abilities	   to	   disperse.	   Thus,	  
communities	  should	  not	  be	  considered	  in	  isolation,	  but	  as	  part	  of	  a	  regional	  pool	  of	  interacting	  
communities:	   the	  meta-­‐community	   (206).	  Meta-­‐communities	   are	   important	   in	   the	   context	  of	  
the	   human	   microbiome,	   as	   different	   sites	   within	   the	   human	   body	   have	   different	   microbial	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communities	  (6,	  103,	  207,	  208),	  and	  these	  communities	  can	  directly	  or	   indirectly	   interact.	  For	  
example,	   microbes	   in	   arterial	   plaques	   are	   linked	   to	   both	   the	   oral	   and	   gut	   microbiota,	   and	  
macrophages	  provide	  a	  possible	  mode	  of	  dispersal	  (209).	  One	  interesting	  hypothesis	  proposes	  a	  
connection	  between	  altered	  vaginal	  and	  oral	  microbiota	  and	  pre-­‐term	  birth	  (210).	  Disturbances	  
to	   the	   ‘healthy’	   bacterial	   communities	   of	   oral	   cavities	   and	   vaginas—caused	   by	   periodontal	  
disease	   and	   bacterial	   vaginosis,	   respectively—are	   correlated	   with	   increased	   risk	   of	   pre-­‐term	  
birth.	   The	   oral	   and	   vaginal	   microbiomes—for	   example,	   Fusobacterium	   and	   Pseudomonas	  
species—have	   similar	   environmental	   niches	   (squamous	   epithelial	   cells),	   dynamics	   of	   biofilm	  
formation	  and	  identity	  of	  community	  members	  during	  dysbiosis	  (an	  imbalance	  of	  microbiota).	  
Thus,	   although	   there	   is	   the	   potential	   for	   direct	   dispersal	   between	   these	   communities	   due	   to	  
host	   sexual	   behavior,	   there	   is	   also	   potential	   for	   indirect	   interactions	  modulated	   by	   the	   host	  
immune	  system,	  as	  dysbiosis	  in	  one	  locality	  might	  elicit	  an	  immune	  response	  that	  affects	  both	  
communities	   due	   to	   their	   similar	   composition.	   Srinivasan	   and	   colleagues	   suggest	   that	   during	  
dysbiosis,	   the	   vaginal	   and	   oral	   communities	   should	   be	   considered	   similarly	   for	   diagnosis	   of	  
individuals	  at	  risk	  for	  pre-­‐term	  birth.	  Salmonella	  typhimurium	  has	  also	  been	  shown	  to	  interact	  
with	   the	   host	   by	   inducing	   the	   production	   of	   tetrathionate,	   which	   can	   be	   then	   used	   as	   a	  
respiratory	  source	  by	  S.	  Typhimurium	  to	  indirectly	  compete	  with	  other	  gut	  microbes	  (211).	  
Interactions	  with	  host	  ecosystems.	  Ecosystems	  are	  an	  ongoing	  dialogue	  between	  chemical	  and	  
physical	   conditions,	   and	  biology:	   the	   environment	   selects	   for	   organisms	   capable	   of	   surviving,	  
which	   in	   turn	  alter	   the	  environment	   to	  become	  more	   favorable	   for	   their	   success.	  Among	   the	  
most-­‐important	   microbial	   interactions	   with	   ecosystems	   are	   nutrient	   and	   carbon	   cycling.	   For	  
example,	   bacterial	   communities	   associated	  with	   soils	   and	   legumes	  modify	   forms	   of	   nitrogen	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(NH4
+,	   N2,	   NO2
−,	   NO3
−),	   which	   makes	   them	   available	   to	   plants	   or	   the	   atmosphere.	   Recent	  
experimental	   research	   on	   soils	   from	   different	   ecosystems	   showed	   that	   soil	   microbial	  
communities	   are	   predictably	   structured	   by	   the	   amount	   and	   quality	   of	   carbon	   and	   nitrogen	  
available	   (212),	   as	   are	   plants	   (for	   examples,	   see	   (213-­‐215).	   Similarly	   to	   soil	   microbial	  
communities,	  human	  microbial	  communities—such	  as	  gut	  communities—are	  influenced	  by	  the	  
types	  and	  availability	  of	  electron	  donors	  and	  acceptors.	  For	  example,	  24-­‐h	  starvation	  of	  mice	  
leads	   to	  alteration	  of	   the	  gut	  community	   (137),	   and	  one	  day	  after	  a	   shift	   from	  a	   low-­‐fat	   to	  a	  
western-­‐human-­‐equivalent	   diet,	   the	   gut	   microbial	   community	   of	   gnotobiotic	   mice	   changed	  
radically	  (216).	  Similarly,	  the	  response	  of	  Burmese	  pythons	  to	  nutrition	  during	  the	  feeding	  cycle	  
is	   systematic	   across	   animals	   (217).	   Interestingly,	   in	   all	   cases,	   increased	  nutrient	   flux	   causes	   a	  
substantial	   shift	   in	   the	   ratio	   of	   Firmicutes	   to	   Bacteroidetes,	   probably	   reflecting	   competition	  
between	   copiotrophs	   and	   oligotrophs,	   especially	   in	   carbohydrate-­‐rich	   diets.	   The	   effect	   of	  
nutrition	  on	  human	  infants—in	  particular	  the	  switch	  from	  breastfeeding	  to	  solid	  food—is	  also	  
profound	  (see	  Temporal	  dynamics).	  
Interactions	  with	  predators:	  microbiome	  and	  virome.	  Other	   important	   interactions,	  especially	  
for	   bacterial	   communities,	   are	   with	   their	   bacteriophage	   predators	   (218,	   219).	   From	   oceans	  
(220)	  to	  human	  bodies	  (221),	  the	  number	  of	  viruses	  and	  virus-­‐like	  particles	  outnumber	  bacteria	  
by	  orders	  of	  magnitude.	   Studies	  of	  host–phage	  dynamics	   in	   aquatic	  ecosystems	   indicate	   that	  
phages	  can	  affect	   the	  diversity	  and	  abundance	  of	  bacterial	   species	  or	   strains	   in	  a	   community	  
(222,	   223).	   However,	   one	   study	   on	   the	   phages	   of	   human	   fecal	  microbiota	   suggests	   that	   this	  
might	  not	  always	  be	  the	  case	  (224).	  Accordingly,	  the	   interactions	  between	  viral	  and	  microbial	  
consortia	  are	  complex	  and	  structured	  by	  the	  environment	  (225).	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Ecological	   theory	   has	   been	   developed	   from	   other	   predator–prey	   relationships;	   one	   classic	  
example	  is	  the	  ‘red	  queen’	  hypothesis,	  named	  after	  the	  character	  in	  Lewis	  Carroll's	  Through	  the	  
Looking	   Glass.	   This	   hypothesis	   refers	   to	   the	   evolutionary	   arms	   race	   that	   can	   occur	   between	  
predator	  and	  prey,	  in	  which	  both	  must	  keep	  ‘running’—random	  mutations	  that	  result	  in	  fitness	  
advantages	  for	  predation	  or	  escape,	  respectively—to	  stay	  in	  the	  same	  place	  (226).	  For	  example,	  
bacteria	  and	  archaea	  have	  developed	  mechanisms	  to	  protect	  themselves	  from	  phages	  through	  
the	  duplication	  of	  genetic	  material—such	  as	  clustered,	  regularly	  interspaced,	  short	  palindromic	  
repeats	   (CRISPRs).	   CRISPRs	   act	   as	   genetic	  markers	   of	   a	   past	   immune	   response	   to	   phages	   or	  
other	   exogenetic	   material	   such	   as	   plasmids.	   CRISPRs	   can	   be	   shared	   among	   environmental	  
bacterial	   communities	   to	   protect	   them	   from	   adverse	   environments	   (227).	   CRISPRs	   might	  
provide	  an	   important	  window	   into	   the	  history	  of	   interactions	  between	  phage	  and	  bacteria	  or	  
archaea	   within	   the	   human	   microbiota.	   An	   interesting	   research	   path	   is	   to	   understand	   the	  
interactions	  between	  viruses,	  host	  microbiome	  and	  host	  genetics,	  and	  their	  role	  in	  the	  health	  of	  
the	  host.	  For	  example,	  the	  combination	  of	  a	  specific	  virome	  and	  the	  gene	  variant	  Atg16L1	  in	  the	  
host	   can	   lead	   to	   Crohn's	   disease	   (228)	   or	   inflammatory	   bowel	   disease	   (229).	   Furthermore,	  
commensal	  bacteria	  can	  modulate	   the	  host	   immune	  response	  against	   influenza	  A	  virus	   (230).	  
These	  studies	  provide	  an	  insight	  into	  the	  crucial	  role	  that	  these	  interactions	  have	  in	  the	  health	  
of	  the	  host.	  
Spatial	  distributions	  
Understanding	  the	  distribution	  of	  species	  on	  Earth	  is	  a	  focus	  in	  ecology.	  A	  sub-­‐discipline,	  known	  
as	  biogeography,	  is	  the	  study	  of	  the	  way	  the	  distribution	  and	  abundance	  of	  species	  change	  over	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time	  at	  the	  regional	  or	  continental	  scales.	  Assessments	  of	  microbial	  diversity	  have	  shown	  that	  
the	   deterministic—such	   as	   biotic	   and	   abiotic	   interactions—and	   stochastic—such	   as	   dispersal	  
ability—processes	   that	   structure	   plant	   and	   animal	   distributions	   also	   control	   microbial	  
distributions	   (reviewed	   in	   (231)).	   Microbial	   biogeography	   has	   been	   particularly	   useful	   in	  
mapping	  occurrences	  of	  disease-­‐relevant	  microbes	  and,	  more	   recently,	  has	  helped	   to	  explain	  
their	   geographical	   patterns	   of	   distribution,	   such	   as	   the	   spread	   of	   antibiotic	   resistance	   in	  
Escherichia	   coli,	   Salmonella	   enterica	   and	   Vibrio	   vulnificus	   (232-­‐234).	   Additionally,	  
biogeographical	   studies	   of	   soil	  microbes	   have	   revealed	   consistent	   patterns	   of	   distribution	   at	  
both	  species	  and	  community	  levels	  (53,	  64,	  79,	  217,	  235).	  Similarly,	  determining	  the	  drivers	  of	  
spatial	  patterns	  on	  and	   in	   the	  human	  body	  will	   require	   tools	   from	   the	   field	  of	  biogeography.	  
Similarly	  to	  the	  natural	  environments	  on	  Earth,	  the	  human	  body	  acts	  as	  an	  ecological	  landscape	  
by	   harboring	   many	   ecosystems	   and	   meta-­‐communities,	   as	   well	   as	   biotic	   and	   abiotic	  
determinants	  and	  barriers	  that	  prevent,	  and	  corridors	  that	  facilitate,	  dispersal.	  For	  instance,	  in	  a	  
study	   of	   transplants	   in	   which	   forearm	   and	   forehead	   skin	   plots	   were	   inoculated	  with	   tongue	  
bacteria,	   forearm	  communities	   remained	  more	   similar	   to	   tongue	   communities	   than	   to	  native	  
forearm	  communities,	  whereas	  forehead	  communities	  reverted	  to	  their	  native	  state	  over	  time	  
(6).	   Excitingly,	   adaptation	   can	   occur	   even	   within	   a	   genome:	   for	   example,	   strains	   of	  
Methanobrevibacter	  smithii	  are	  more	  similar	  in	  identical	  than	  non-­‐identical	  twins	  (236),	  and	  the	  
genetic	  determinants	  of	  group	  A	  streptococcus	  that	  allow	  colonization	  of	  different	  parts	  of	  the	  
body	   are	   beginning	   to	   be	   unraveled	   as	   more	   genomes	   are	   sequenced	   (237).	   Thus,	  
environmental	   characteristics	   such	  as	  dispersal	  barriers	  probably	  also	   shape	   the	  geographical	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distribution	   of	   human-­‐associated	   communities,	   including	   individual	   strains	   of	   species	   within	  
those	  communities.	  
Ultimately,	   understanding	   why	   species	   or	   communities	   occur	   in	   particular	   areas	   can	   help	   to	  
predict	   their	  occurrence.	  Predicting	   spatial	  distributions	   can	  be	   informed	  by	   investigating	   the	  
ecological	  niche—the	  set	  of	  environmental	  factors	  that	  are	  associated	  with	  its	  occurrence—of	  a	  
species.	   The	   abiotic	   conditions	   in	   which	   a	   species	   can	   survive	   define	   its	   fundamental	   niche	  
(238).	   However,	   only	   a	   portion	   of	   the	   fundamental	   niche	   is	   usually	   occupied—that	   is,	   its	  
realized	  niche—because	  biotic	  interactions	  and	  dispersal	  ability	  limit	  the	  potential	  of	  a	  species	  
to	   occupy	   all	   suitable	   habitats.	   In	   microbial	   biogeography,	   the	   predominant	   theory	   is	   that	  
“everything	  is	  everywhere,	  but	  the	  environment	  selects”	  (63,	  239),	  which	  suggests	  that	  because	  
dispersal	   is	  generally	  unlimited	  for	  microbes—in	  contrast	   to	  animal	  systems—a	  realized	  niche	  
might	   be	   controlled	   by	   abiotic	   and	   biotic	   factors	   instead	   of	   dispersal	   ability.	   For	   example,	  
studies	   of	   soil	   microbial	   communities	   indicate	   that	   landscape-­‐scale	   spatial	   variation	   in	  
abundances	   are	   mainly	   driven	   by	   environmental	   parameters	   such	   as	   pH,	   and	   that	   these	  
variables	  can	  be	  used	  to	  accurately	  predict	  the	  large-­‐scale	  distribution	  of	  certain	  communities	  
(51,	   74,	   79).	   Another	   study	   found	   that	   within	   local	   habitats,	   bacterial	   assemblages	   were	  
determined	  by	  biotic	  interactions,	  exhibiting	  specific	  co-­‐occurrence	  patterns	  (64).	  
Ecological-­‐niche	   theory	   is	   useful	   for	   describing	   the	   spatial	   distribution	   of	   human-­‐associated	  
microbial	   communities.	   Similar	   patterns	   might	   emerge	   for	   microbial	   communities	   inhabiting	  
different	  habitats	   in	   the	  body—such	  as	   gut	   compared	  with	   skin—and	  micro-­‐habitats,	   such	  as	  
different	   skin	   sites.	  Characterizing	   these	  habitats	   is	   complicated	  by	   the	   fact	   that	  each	  human	  
harbors	   unique	  microbial	   consortia	   that	   are	   so	   specific	   that	   some	   skin	   sites	   can	   be	   used	   to	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forensically	   identify	   the	  host	   (75,	  106).	  As	   the	  genetics,	  development	  and	  behavior,	   including	  
diet,	  of	  the	  host	  contribute	  to	  the	  composition	  of	  individual	  microbiota,	  each	  person	  essentially	  
functions	   as	   a	   unique	   and	   separate	   ecosystem.	   Despite	   this	   uniqueness,	   communities	   are	  
grouped	  by	  body	  habitat—such	  as	  gut,	  skin	  or	  mouth—across	   individuals	  (6).	  Even	  within	  one	  
type	   of	   body	   habitat,	   the	   skin,	   bacterial	   communities	   are	  more	   similar	   across	   physiologically	  
comparable	  skin	  sites	  than	  in	  topographically	  close	  sites	  (207).	  These	  site-­‐specific	  factors	  make	  
it	  challenging	   to	  develop	  comprehensive	  niche	  models	   for	   the	  human	  microbiota,	  but	  studies	  
show	  that	  micro-­‐habitats	  across	  the	  skin	  can	  be	  quantified,	  as	  exemplified	  by	  a	  recent	  study	  in	  
which	   measurements	   of	   skin	   surface	   temperature,	   surface	   pH	   and	   lipid	   content	   exhibited	  
regional	   variations	   (240).	   Thus,	   modeling	   the	   effects	   of	   specific	   micro-­‐habitats	   on	   microbial	  
communities	   might	   be	   a	   tractable	   problem,	   although	   defining	   the	   niches	   of	   individual	  
community	  members	  remains	  challenging.	  
Temporal	  dynamics	  
In	  the	  same	  way	  that	  microbial	  communities	  are	  expected	  to	  change	  across	  a	  landscape,	  they	  
are	   also	   dynamic	   in	   time.	   Community	   ecology	   provides	   a	   framework	   for	   understanding	  
temporal	  dynamics,	   including	  the	  concepts	  of	  succession,	   resilience	  and	  community	   turnover.	  
In	  general,	  time-­‐series	  studies—in	  which	  microbial	  communities	  are	  sampled	  repeatedly	  at	  the	  
same	  site	  over	  time—aim	  to	  identify	  deviations	  from	  an	  equilibrium	  state,	  and	  are	  essential	  for	  
understanding	   the	   natural	   variability	   and	   trajectories	   of	   microbial	   communities.	   Microbial	  
community	  dynamics	  have	  been	  characterized	   in	  time-­‐series	  data	  from	  several	  environments,	  
including	   the	   human	   body	   (Fig	   5;	   (6,	   7)),	   oceans	   (241),	   lakes	   (242)	   and	   soils	   (243,	   244).	   This	  
temporal	  component	  allows	  for	  identification	  of	  both	  persistent	  and	  transient	  components	  of	  a	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community	   (203),	  measurement	  of	   robustness	  and	   resilience	   to	  external	  perturbations	   (245),	  
and	  improved	  understanding	  of	  dispersal	  and	  migration	  patterns	  (246).	  
	  
	  
Figure	  5.	  Variability	  of	  the	  human	  microbiota.	  The	  plot	  shows	  the	  first	  two	  axes	  of	  the	  principal	  
coordinate	   analysis	   (PCoA),	   which	   capture	   the	   differences	   and	   similarities	   between	  
communities	   in	   each	   biological	   sample.	   The	   area	   of	   each	   polygon	   represents	   the	   variability	  
within	  clusters	  of	  the	  samples	  in	  each	  study,	  indicating	  that	  the	  human	  microbiome	  separation	  
is	  due	   to	   its	  origin	   (gut,	   skin,	  mouth	  and	  urogenital)	  and	   that	   there	   is	  as	  much	  variation	  over	  
time	  in	  one	  person	  as	  there	  is	  between	  adults	  in	  a	  community.	  Samples	  from	  (6),	  27	  sites	  in	  7–9	  
healthy	   adults	   are	   shown	   in	   red	  and	   samples	   from	   (7),	   3	   sites	   in	   two	  adults	   over	   1	   year,	   are	  
shown	  in	  blue.	  
	  
Succession	  is	  a	  process	  that	  begins	  in	  a	  ‘blank	  slate’	  environment;	  pioneer	  species	  colonize	  the	  
environment	   first,	   altering	   it	   to	   be	   hospitable	   to	   secondary	   colonizers.	   This	   process	   then	  
continues	  until	  a	  climax	  community	  is	  reached	  around	  an	  equilibrium	  composition.	  Succession	  
has	  been	  widely	  observed,	  such	  as	   in	  microbial	  communities	  that	  colonize	   leaf	  surfaces	  (247).	  
Primary	  succession—first	  observed	   in	   forests	  affected	  by	  fire—occurs	  as	  pioneer	  species	  alter	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the	  organic	  composition	  of	  the	  post-­‐burn	  soil,	  making	  it	  suitable	  for	  subsequent	  colonizers.	   In	  
boreal	   forests,	   a	   functional	   trajectory	   proceeds	   from	   herbs	   and	   forbs,	   shrubs,	   young	   forest	  
(saplings),	  mature	  forest	  and,	  finally,	  climax	  forest,	  150–300	  years	  after	  the	  fire	  (248).	  
Although	   the	   functional	   roles	   of	   microbial-­‐community	   members	   during	   succession	   are	   more	  
difficult	  to	  discern	  than	  those	  of	  higher	  plants,	  the	  early	  colonization	  of	  the	  human	  gut	  provides	  
an	   excellent	   case	   study	   for	   microbiota	   succession.	   Neonates	   are	   thought	   to	   develop	   in	   a	  
microbe-­‐free	  environment	  until	  delivery,	  when	  they	  are	  exposed	  for	  the	  first	  time	  to	  a	  variety	  
of	   bacteria.	   During	   vaginal	   birth,	   the	   infant	   is	   first	   exposed	   to	  microbes	   present	   in	   the	   birth	  
canal	   of	   the	   mother,	   an	   environment	   that	   is	   mostly	   colonized	   by	   Lactobacillus	   (249).	   By	  
contrast,	   babies	  delivered	  by	   caesarean	   section	  do	  not	   receive	   this	   initial	   exposure	   and	   their	  
bacterial	  communities	  resemble	  those	  found	  on	  skin	  (103).	  A	  similar	  study	  demonstrated	  that	  
gut	  diversity	  steadily	  increases	  from	  birth	  until	  two	  and	  a	  half	  years	  of	  age	  (83).	  Inter-­‐individual	  
reproducibility	  of	  gut-­‐community	  succession	  has	  also	  been	  examined	  in	  a	  cohort	  of	  14	  full-­‐term	  
infants	  over	  the	  first	  year	  of	  life	  (250).	  Composition	  varied	  from	  infant	  to	  infant,	  as	  observed	  in	  
adults	  (75).	  Although	  there	  was	  no	  common	  pattern	  of	  succession	  observed	  across	  infants,	  the	  
communities	   in	   each	   baby	   showed	   a	   recognizable	   temporal	   pattern.	   In	   this	   study,	   mothers	  
provided	   vaginal,	   milk	   and	   stool	   samples;	   the	  microbiomes	   of	   the	  milk	   and	   vaginal	   samples	  
clustered	  with	  the	  earliest	  gut	  microbiomes	  of	  the	  infants.	  
The	   innate	   and	   adaptive	   immune	   system	   of	   the	   infant,	   which	   can	   exert	   pressure	   on	   the	  
microbiota,	   is	   highly	   dynamic	  during	   the	   first	   year	  of	   life.	   The	  development	  of	   the	   infant	   gut	  
microbiota	   is	   affected	   by	   passive	   antibodies,	   oligosaccharides	   and	   glycans	   from	   animal	   milk	  
through	  the	  promotion	  of	  Bifidobacterium	  bifidum	  growth	  and	  inhibition	  of	  pathogenic	  species	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(251).	   The	   function	   and	   expression	   of	   toll-­‐like	   receptors	   (TLRs),	   which	   recognize	   various	  
microbial	  products,	  rapidly	  change	  during	  the	  first	  year	  of	  life	  (252).	  At	  birth,	  the	  TLR	  response	  
to	   lipopolysaccharide	   and	   CpG	   (cytosine–guanine	   dinucleotide	   DNA	   sequence)	   regions	   is	  
impaired,	   leading	   to	   reduced	   production	   of	   proinflammatory	   cytokines,	   which	   can	   limit	  
bacterial	  growth	  (253,	  254).	  In	  the	  first	  few	  months	  after	  birth,	  the	  phenotype	  and	  function	  of	  B	  
and	  T	  cells	  in	  the	  lamina	  propria	  of	  the	  large	  intestine	  also	  change	  dramatically.	  The	  majority	  of	  
B	  and	  T	  cells	  in	  cord	  blood	  are	  naive;	  however,	  in	  the	  months	  following	  birth,	  bacteria-­‐specific	  
B-­‐	   and	   T-­‐cell	   memory	   populations	   appear,	   begin	   to	   provide	   protection	   from	   pathogenic	  
microbes,	  and	  presumably	   shape	   the	  commensal	  bacterial	   community	  within	   the	  gut.	   In	   fact,	  
immunoglobulin-­‐A-­‐producing	   B	   cells—which	   are	   important	   for	   the	   control	   of	   microbes	   at	  
mucosal	   surfaces—are	  not	  detected	  until	   12	  days	  after	  birth,	   and	   their	  density	   in	   the	   lamina	  
propria	  steadily	  increases	  even	  after	  3	  months	  of	  age	  (255).	  In	  turn,	  bacterial	  colonization	  of	  the	  
gut	  is	  crucial	  for	  the	  normal	  development	  and	  homeostatic	  maintenance	  of	  mucosal	  immunity	  
(256,	   257).	   Lastly,	   as	   discussed	   elsewhere	   (83,	   258,	   259),	   the	   introduction	   of	   solid	   foods	  
modifies	  the	  structure	  of	  the	  community	  and	  triggers	  the	  change	  towards	  an	  adult	  microbiota.	  
With	   the	   advent	   of	   higher-­‐throughput	   sequencing	   platforms	   (2),	  we	   can	   expect	   to	   see	  more	  
studies	  of	  succession	  at	  higher	  temporal	  resolution	  and	  with	  more	  subjects	   in	  the	  near	  future	  
(Figs	  4,5).	  These	  will	  provide	  insight	  into	  normal	  human	  development,	  recovery	  after	  antibiotic	  
treatment	   or	   other	   drugs,	   and	   progression	   into	   disease	   states,	   including	   in	   some	   cases	  
remission	  from	  those	  states.	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Time-­‐series	   data	   can	   also	   be	   used	   to	   investigate	   the	   responses	   of	  microbial	   communities	   to	  
disturbances.	   In	   disturbance	   ecology,	   a	   robust	   community	   is	   one	   that	   is	   either	   resistant	  
(changes	  minimally)	  or	  quickly	  resilient	  (recovers	  to	  the	  pre-­‐disturbance	  state)	  to	  disturbance.	  
Microbial	   responses	   to	   disturbance	   have	   been	   observed	   in	   soil,	   aquatic	   and	   engineered	  
environments.	  For	  example,	  elevated	  atmospheric	  carbon-­‐dioxide	  levels—an	  example	  of	  a	  long-­‐
term	  disturbance—initiated	  a	  different	  response	  in	  bacterial	  and	  fungal	  species	  in	  rhizosphere	  
soil;	  specific	  community	  members	  were	  more	  strongly	  affected	  than	  others,	  suggesting	  complex	  
response	   patterns	   that	  might	   not	   be	   uncovered	   using	   bulk-­‐microbial	   measurements	   such	   as	  
respiration	   and	   production	   (260).	   Aquatic	   microbial	   communities	   exhibited	   a	   repeatable	  
trajectory	  of	   response	  and	  recovery	  after	   typhoons	  mixed	   the	  water	  column	   in	  a	  sub-­‐tropical	  
lake,	  demonstrating	  a	  remarkable	  predictability	  in	  community	  dynamics	  after	  pulse-­‐disturbance	  
events	  (95).	  Finally,	  the	  pre-­‐disturbance	  composition	  of	  methanogenic-­‐bioreactor	  communities	  
was	  important	  for	  functional	  stability	  after	  glucose	  amendment	  (261,	  262).	  These	  studies	  show	  
that,	   despite	   similar	   initial	   performance	   across	   microbial	   communities,	   compositional	  
differences	  have	  implications	  for	  overall	  functional	  stability	  after	  disturbance.	  These	  examples	  
and	  others	  suggest	  some	  recovery	  of	  the	  post-­‐disturbance	  community,	  either	  in	  composition	  or	  
function.	  However,	  no	  consistent	  recovery	  has	  been	  documented,	  possibly	  because	  insufficient	  
post-­‐disturbance	  observation	  data	  are	  available	  (263).	  
	  
The	   principles	   of	   disturbance	   ecology—including	   response,	   resilience,	   recovery	   and	  
succession—are	  also	  relevant	  to	  host-­‐associated	  microbiota.	  An	  example	  of	  a	  perturbation	  with	  
temporary	   effects	  was	   described	   in	   a	   study	   of	   patients	   receiving	   a	   transplant	   of	   small-­‐bowel	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microbiota	   (264).	   After	   transplant,	   patients	   harbored	   a	   higher	   proportion	   of	   lactobacilli	   and	  
enterobacteria;	   however,	   the	   community	   eventually	   reverted	   to	   pre-­‐transplantation	  
composition—dominated	  by	  Bacteroides	  and	  Clostridia—showing	  resilience.	  Antibiotics	  are	  also	  
known	  to	  alter	  bacterial	   composition	  of	   the	  gut	   flora	   (170,	  265),	  and	  prolonged	  use	  prevents	  
recovery	   (96,	   266).	   These	   studies	   show	   that	   antibiotics	   can	   modify	   the	   gut	   environment	   by	  
killing	  both	  pathogens	  and	  dominant	  community	  members,	  and	  that—if	  given	  an	  opportunity—
normally	   non-­‐competitive	   taxa	   can	   flourish.	   However,	   the	   eventual	   recovery	   of	   the	   gut	  
community	  mimics	  what	  has	  been	  observed	  in	  other	  microbial	  communities,	  and	  suggests	  that	  
prediction	  might	  be	  possible.	  
The	  future:	  prediction	  and	  personalized	  medicine	  
The	   initial	  wave	  of	  human	  microbiome	  projects	  sought	   to	  describe	   the	  bacterial	  communities	  
harbored	  in	  the	  human	  body.	  Although	  the	  fungal,	  viral	  and	  archeal	  populations	  have	  not	  been	  
as	   deeply	   characterized	   as	   bacterial	   communities,	   their	   study	   is	   undoubtedly	   of	   great	  
importance	   to	   better	   understanding	   their	   effects	   in	   the	   host.	   This	   initial	   characterization	   has	  
enhanced	  our	  understanding	  of	  the	  differences	  between	  healthy	  and	  diseased	  states,	  such	  as	  in	  
the	  distinctive	  nature	  of	  obesity-­‐	  and	  lean-­‐associated	  bacterial	  communities	  (5).	  However,	  the	  
large	  inter-­‐individual	  variability	  of	  microbiota	  can	  impede	  diagnosis	  of	  all	  but	  the	  most	  common	  
conditions,	  and	  more	  comprehensive	  temporal	  and	  spatial	   information	   is	  necessary	   to	   inform	  
personalized	  medicine;	  several	  studies	  have	  begun	  to	  address	  this	  (249,	  267).	  
Although	   species-­‐level	   characterization	   of	   the	   bacterial	   communities	   inhabiting	   various	   body	  
sites	  has	  provided	  insight	  into	  our	  microbial	  selves,	  current	  and	  future	  studies	  using	  techniques	  
such	   as	   whole-­‐genome	   shotgun	   sequencing	   will	   also	   provide	   a	   description	   of	   the	   functional	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diversity	   in	   those	   communities.	   A	   recent	   study	   has	   shown,	   for	   example,	   that	   the	   gut	  
communities	  of	   different	  mammal	   species	   share	   a	   core	   set	  of	   functional	   genes,	   and	   that	   the	  
bacterial	  lineages	  that	  make	  up	  a	  community	  and	  the	  gene	  content	  of	  that	  community	  have	  a	  
similar	   clustering	   pattern	   (268).	   Another	   active	   area	   of	   research	   aims	   to	   understand	   the	  
interactions	  between	  the	  microbiome	  and	  the	  virome	  in	  the	  distal	  intestine	  (224),	  the	  infant	  gut	  
(269)	  and	  the	  lung	  (270).	  
Research	   in	  human	  microbial	  communities	  has	  already	  benefited	  from	  incorporating	  methods	  
and	   concepts	   from	   ecology	   to	   collect	   and	   analyze	   the	   wealth	   of	   data	   generated	   by	   new	  
sequencing	   technologies.	   The	   spatial	   and	   temporal	   characterization	   of	   the	   microbiota	   in	  
different	   populations,	   in	   particular,	   has	   provided	   deeper	   insights	   into	   the	   dynamics	   of	  
commensal	   bacteria	   and	   their	   resistance	   and	   resilience	   to	   perturbations	   in	   the	   human	  body.	  
The	   ability	   to	   analyze	   more	   microbial	   communities	   at	   lower	   cost	   will	   allow	   us	   to	   test	   the	  
reproducibility	  of	  these	  conclusions	  in	  subjects	  of	  different	  ages,	  diets	  and	  ethnicities,	  and	  with	  
different	   drug-­‐exposure	   histories.	   At	   the	   same	   time,	   the	   ability	   to	   exploit	   many	   samples—
especially	  in	  the	  context	  of	  time	  series	  with	  perturbations—will	  allow	  us	  to	  identify	  networks	  of	  
interactions	   among	   microbial	   taxa	   and	   determine	   which	   species	   can	   be	   most-­‐effectively	  
targeted	   for	   therapeutic	   applications—either	   by	   removal	   with	   antibiotics,	   addition	   with	  
probiotics	  or	  encouragement	  with	  prebiotics.	  Given	  the	  prolific	  and	  myriad	  types	  of	  data	  that	  
are	   sure	   to	   emerge	   with	   the	   incorporation	   of	   whole-­‐genome	   shotgun	   sequencing	   and	   viral	  
metagenomics,	  continuing	  to	  frame	  human	  microbiome	  studies	  in	  ecological	  terms	  will	  be	  even	  
more	  important.	  This	  broader	  and	  ecologically	  informed	  understanding	  of	  our	  microbial	  selves	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will	  be	  key	  for	  truly	  personalized	  medicine	  that	  is	  based	  not	  on	  the	  human	  genome,	  in	  which	  we	  
are	  all	  99.9%	  the	  same,	  but	  on	  the	  microbiome,	  in	  which	  we	  can	  differ	  immensely.	  
	  
Thus	   in	   this	   chapter,	   I	   have	   motivated	   the	   importance	   of	   spatially	   explicit	   studies	   in	  
understanding	   the	   human	   microbiome.	   In	   the	   next	   chapter,	   I	   will	   build	   on	   this	   topic	   by	  
introducing	   SitePainter,	   a	   software	   tool	   to	   create	   choropleth	   maps	   based	   on	   microbial	  
community	  data.	  SitePainter	  allows	  the	  user	  to	  see	  spatial	  patterns	  in	  the	  biogeography	  of	  the	  
microorganism	  communities	  via	  a	  web-­‐enabled	  graphical	  user	  interface.	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CHAPTER	  
V. SitePainter:	  a	  tool	  for	  exploring	  biogeographical	  patterns	  
The	   need	   for	   new	   visualization	   techniques	   that	   facilitate	   the	   analysis	   of	   the	   spatially	   explicit	  
datasets	  that	  advances	  in	  DNA	  sequencing	  technology	  now	  allow	  us	  to	  obtain	  led	  me	  to	  create	  
SitePainter.	  SitePainter	  allows	  a	  user	  to	  visually	  explore	  α	  and	  β	  diversity	  patterns	   in	  spatially	  
explicit	  microbial	   ecology	   data.	   This	   chapter	  was	   published	   in	   (271),	   and	  my	   role	   as	   the	   first	  
author	  was	  to	  write	  all	  the	  code	  and	  write	  the	  published	  paper.	  	  
	  
Introduction	  
As	   sequencing	   capacity	   increases,	  microbial	   community	  analysis	   is	  undergoing	  a	   revolution	   in	  
throughput.	  Where	  it	  was	  once	  a	  monumental	  task	  just	  to	  analyze	  microbial	  communities	  in	  a	  
handful	  of	  samples,	  we	  can	  now	  process	  thousands	  of	  samples	   in	  a	  single	  sequencing	  run	  (2).	  
Accordingly,	   instead	  of	  describing	   those	  communities	   in	  a	   few	  samples	  collected	  under	  a	   few	  
specific	  conditions,	  we	  can	  now	  perform	  comprehensive	  spatial	  sampling,	  exploring	  interactions	  
among	  members	   of	   the	  microbial	   communities	   and	   revealing	   large-­‐scale	   spatial	   dynamics	   (2,	  
48,	  102,	  272,	  273).	  
However,	  the	  power	  of	  these	  analyses	  is	  often	  limited	  by	  our	  ability	  to	  visualize	  the	  data.	  When	  
analyzing	  biogeographical	   data,	   researchers	  would	   like	   to	   know	  where	   specific	  microbes	   live,	  
how	  abundant	  they	  are	  and	  whether	  there	  are	  any	  notable	  patterns	  relating	  microbial	  taxa	  to	  
each	  other	  or	  to	  environmental	  conditions.	  Traditional	  ordination	  methods	  for	  visualizing	  large	  
numbers	   of	   microbial	   communities	   such	   as	   Principal	   Coordinates	   Analysis	   (PCoA)	   (274)	   are	  
extremely	  useful	  for	  reducing	  the	  dimensionality	  of	  vast	  multivariate	  datasets,	  but	  the	  patterns	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are	  often	  unclear,	  especially	  when	  the	  results	  do	  not	  map	  easily	  onto	  the	  sampling	  structure.	  
For	  example,	  it	  may	  not	  be	  clear	  that	  all	  the	  points	  that	  cluster	  together	  at	  one	  end	  of	  an	  axis	  




Figure	   6.	   SitePainter	   illustration	   of	   microbial	   community	   patterns	   in	   a	   human	   hand.	   (A)	  
SitePainter	   user	   interface:	   (1)	   file	   image	   manipulation,	   (2)	   metadata	   loading	   and	   processing	  
menu,	   (3)	   coloring	   scheme	   and	   (4)	   interactive	   menu.	   (B)	   The	   α	   -­‐diversity	   analysis	   showing	  
relative	  abundance	  of	  bacterial	   taxa	  on	  the	  hand:	   low	  values	   in	  blue	  an	  high	  values	   in	  red	  (1)	  
Gammaproteobacteria,	  (2)	  Bacilli	  and	  (3)	  Actinomycetales.	  (C)	  The	  β	  -­‐diversity	  analysis	  showing	  
overall	   similarities	   and	   differences	   among	   samples:	   (1)	   3D	   PCoA	   axis	   where	   each	   point	  
represents	   a	   sample	   and	   each	   sample	   is	   colored	   independently	   and	   (2)	   first	   two	   axes	   of	   the	  
PCoA	  analysis,	  where	  similar	  colors	  represent	  samples	  similar	  to	  each	  other	  along	  a	  given	  axis	  in	  
the	  abstract	  ordination	  space,	  with	  low	  values	  in	  blue	  and	  high	  values	  in	  red.	  
	  
To	   address	   this	   key	   barrier	   to	  microbial	   community	   research,	  we	   developed	   SitePainter	   that	  
provides	  compelling	  visualizations	  that	  allow	  the	  researcher	  to	  better	  explore	  spatial	  patterns	  in	  
microbial	  communities.	  SitePainter	  allows	  the	  user	  to	  draw	  or	  import	  representative	  images	  for	  
biogeographical	  sites	  [in	  the	  example,	  we	  show	  a	  human	  hand	  (Fig.	  6B–C),	  although	  any	  picture	  
from	  micro-­‐	   to	   landscape-­‐scale	   is	   possible]	   and	   regions	   within	   that	   site	   (e.g.	   a	   finger,	   palm,	  
finger	  tips,	  etc.).	  Once	  the	  biogeographical	   image	   is	  drawn,	  the	  user	  can	   import	  tab-­‐delimited	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text	   files,	   such	  as	   those	  produced	  by	  Quantitative	   Insights	   Into	  Microbial	  Community	   (QIIME)	  
(17)	  to	  map	  onto	  their	  image.	  For	  example,	  it	  is	  often	  useful	  to	  plot	  the	  α	  -­‐diversity	  (the	  number	  
of	  species	  present	  in	  each	  sample),	  taxonomy	  summaries	  (the	  abundance	  of	  particular	  kinds	  of	  
species	   in	   the	   sample)	   and/or	   β	   -­‐diversity	   (the	   overall	   similarities	   and	   differences	   among	  
samples).	  
SitePainter	  
SitePainter	   is	  a	   software	  package	  with	  an	   interactive	  user	   interface,	   implemented	  with	  HTML	  
and	  Javascript,	  which	  accepts	  Scalable	  Vector	  Graphics	  (SVG)	  images	  and	  annotates	  them	  with	  
per	  sample	  data	  defined	  by	  the	  user.	  As	  an	  example	  of	  usage,	  we	  show	  the	  biogeography	  of	  the	  
human	  hand	  and	  assign	  bacterial	   information	  based	  on	  QIIME-­‐formatted	  files.	  The	  main	  work	  
areas	  of	  SitePainter	  are:	  (i)	  file	   image	  manipulation	  that	  allows	  the	  user	  to	  load	  and	  save	  SVG	  
images;	  (ii)	  the	  metadata	  loading	  and	  processing	  menu,	  where	  the	  user	  can	  select	  the	  metadata	  
(tab-­‐delimited	   format)	   to	   be	   displayed	   in	   combination	   with	   the	   images;	   (iii)	   the	   coloring	  
scheme,	  where	  the	  user	  can	  select	  how	  to	  represent	  low	  and	  high	  values,	  reset	  the	  image	  color	  
or	  show/hide	  the	  display	  of	  lines	  and	  absent	  paths,	  to	  show	  more	  compelling	  images;	  and	  (iv)	  
the	  interactive	  menu	  that	  allows	  the	  user	  to	  work	  with	  previous	  selections	  to	  find	  patterns	  that	  
may	  not	  have	  been	  apparent	  when	  using	  other	  visualization	  tools	  and	  techniques	  (Fig.	  6A).	  
To	  illustrate	  the	  effectiveness	  of	  SitePainter,	  we	  show	  the	  results	  of	  a	  study	  in	  which	  different	  
regions	  from	  a	  subject's	  hand	  were	  sampled	  for	  microbes.	  The	  subject's	  hand	  was	  outlined,	  and	  
each	   region	  divided	   into	   smaller	  areas	   that	  were	   then	  sampled	  using	  cotton	   swabs	  dipped	   in	  
saline	   solution.	   Using	   SitePainter,	   we	   were	   able	   to	   rapidly	   deduce	   which	   bacteria	   were	   in	  
different	  regions	  of	  the	  hand,	  along	  with	  a	  graphical	  representation	  of	  microbial	  abundances	  by	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processing	  the	  sequence	  data	  with	  QIIME	  (17)	  and	  mapping	  the	  abundance	  of	  each	  taxon	  onto	  
the	   hand	   image	   (Fig.	   6B).	   Using	   this	   display,	   we	   can	   immediately	   see	   that	  
Gammaproteobacteria	  is	  present	  in	  the	  palm,	  Bacilli	  are	  more	  visible	  toward	  the	  fingertips	  and	  
Actinomycetales	   is	  present	   in	  only	  one	  area	  of	   the	  hand.	  This	   feature	   thus	  allows	  the	  user	   to	  
easily	  visualize	  the	  distribution	  and	  abundance	  of	  microbes	  across	  sites.	  
Going	  beyond	  the	  abundances	  of	   individual	  microbial	  taxa,	  SitePainter	  also	  allows	  the	  user	  to	  
view	  similarities	  and	  differences	  at	  the	  whole-­‐community	  level	  by	  loading	  the	  PCoA	  axis	  of	  the	  
microbial	   data	   to	   reveal	   patterns	   that	   are	   not	   obvious	   in	   the	   PCoA	  plot	   but	   are	   immediately	  
obvious	  when	  displayed	  in	  the	  context	  of	  the	  site	  itself	  (Fig.	  6C:	  compare	  left	  panel	  to	  the	  right	  
two	  panels.	   In	  this	  case,	  we	  can	  see	  a	  clear	  gradient	  from	  the	  thumb	  and	  index	  fingers	  to	  the	  
left-­‐bottom	  corner	  of	   the	  hand;	  additionally	  we	  can	  see	   that	   the	  distal	  phalanges	  are	  similar,	  
maybe	  due	  to	  constant	  contact).	  
In	   addition	   to	   analyses	   of	   microbial	   taxa,	   as	   shown	   here,	   SitePainter	   can	   also	   be	   used	   to	  
interpret	   the	   abundance	   of	   genes	   or	   pathways	   across	   sites	   for	   metabolic	   studies.	   Several	  
further	   examples	   can	   be	   found	   in	   the	   Human	   Microbiome	   Project	   web	   site:	  
http://hmpdacc.org/sp/.	   These	   examples	   analyze	   the	   entire	   Human	  Microbiome	   Project	   (25,	  
171)	   dataset	   at	   several	   taxonomic	   levels,	   and	   at	   several	   different	   levels	   of	   functional	  
classification	  for	  shotgun	  metagenomic	  reads.	  We	  expect	  that	  this	  will	  be	  a	  useful	  community	  
resource	  for	  those	  trying	  to	  interpret	  the	  complexities	  of	  the	  human	  microbiome.	  
Conclusions	   	  
SitePainter	  provides	  a	  user-­‐friendly	  tool	  that	  allows	  rapid,	  clear	  visualization	  of	  microbial	  data	  
on	  arbitrary	  user-­‐supplied	  images.	  Additionally,	  it	  contains	  several	  user	  interface	  features,	  such	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as	  rapid	  switching	  between	  taxa/coordinates	  and	  animations	  of	  e.g.,	  diversity	  overtime.	  These	  
features	  facilitate	  fast	  exploratory	  analyses	  of	  spatial	  data.	  We	  believe	  that	  SitePainter	  will	  have	  
a	  large	  impact	  on	  the	  field,	  especially	  in	  the	  case	  of	  diseases	  with	  complex	  spatial	  structure	  such	  
as	  psoriasis	  and	  ulcerative	  colitis,	  and	  also	  in	  large-­‐scale	  environmental	  sampling	  projects	  such	  
as	  the	  Earth	  Microbiome	  Project	  (26).	  
	  
The	  SitePainter	  documentation	  can	  be	  found	  in	  Appendix	  1.	  
	  
In	  the	  next	  chapter	  I	  will	  present	  a	  new	  computational	  technique	  based	  on	  cloud	  computing	  to	  
analyze	   and	   combine	   large	   16S	   rRNA	  microbial	   community	   studies	   and	   some	   of	   the	   human	  
health	  interesting	  results	  provided	  by	  it.	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CHAPTER	  
VI. The	  Human	  Microbiome	  across	  space	  and	  time:	  characterizing	  our	  microbial	  household	  
Microbial	   community	   researchers	   are	   confronted	   with	   computational	   barriers	   due	   to	   the	  
explosion	  of	   samples	  and	   sequences	   created	  by	  new	  sequencing	   technologies.	   This	  explosion	  
also	   allows	   microbial	   ecologist	   to	   study	   longer	   temporal	   datasets	   that	   were	   previously	  
impossible	  to	  create,	  as	  described	  in	  Chapter	  2	  and	  3.	  This	  computational	  barrier	  has	  created	  a	  
new	  window	  of	  opportunity	   for	   computer	   scientists	   to	  help	   the	  microbial	   community	   field	   to	  
progress	  from	  simple	  ad	  hoc	  scripts	  to	  formal	  computational	  pipelines	  in	  order	  to	  make	  sense	  
of	   these	   ever-­‐growing	   datasets,	   as	   described	   in	   Chapter	   1.	   In	   this	   chapter,	   I	   describe	   a	   new	  
computational	   pipeline,	   based	   on	   QIIME	   and	   StarCluster,	   that	   allows	   researchers	   to	   process	  
these	  vast	  datasets	  and	  combine	  them	  using	  the	  cloud.	  Additionally,	  I	  present	  some	  examples	  
of	   important	   microbial	   community	   human	   health	   related	   insights	   obtained	   by	   using	   this	  
pipeline	   and	   the	   combination	   of	   multiple	   studies.	   Finally,	   I	   present	   the	   state	   of	   the	   art	   for	  
representing	  temporal	  analyses	  while	  comparing	  microbial	  communities.	  
	  
Introduction	  
As	  a	  consequence	  of	  the	  recent	  advances	  in	  sequencing	  technologies,	  microbial	  ecologists	  have	  
moved	  from	  collecting	  a	   few	  samples	   from	  an	  environment	  towards	   large	  multisite,	   temporal	  
and	   spatial	   explicit	   studies.	   This	   new	   opportunity	   has	   also	   created	   an	   analytical	   obstacle	  
because	   of	   the	   large	   amount	   of	   sequences	   that	   newer	   technologies	   yield.	   One	   approach	  
researchers	   have	   taken	   to	   address	   this	   increasing	   analytical	   problem	   is	   to	  move	   from	   single-­‐
developer,	   individual	   computational	   scripts	   towards	   large	  multi-­‐developer	   software	  pipelines,	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as	   reviewed	   in	   (1,	   275).	   Nevertheless,	   this	   solution	   has	   created	   a	   new	   problem:	   where	   can	  
microbial	  researchers	  run	  these	  larger	  and	  more	  complex	  computational	  tools	  to	  make	  sense	  of	  
their	  data?	  (276)	  
Cloud	  computing,	  i.e.	  hardware	  and	  software	  resources	  that	  are	  delivered	  over	  the	  Internet	  to	  
users,	  have	  changed	  the	  analytical	  paradigm	  throughout	  the	  biological	  sciences,	  as	  reviewed	  in	  
(276,	  277).	  Cloud	  computing	  has	  also	  enabled	  many	  new	  software	  tools,	  reviewed	  in	  (1).	  These	  
alternatives	   have	   opened	   a	   new	   space	   in	  which	  microbial	   ecologists	   can	   analyze	   their	   larger	  
datasets.	  Additionally,	   it	  has	  created	  a	  new	  need:	   the	  currently	  established	  pipelines	  must	  be	  
modified	  to	  take	  advantage	  of	  the	  opportunities	  that	  cloud	  computing	  provides.	  	  
Here	  we	   present	   an	   technique	   using	  Amazon	   EC2	   to	   analyze	   16S	   rRNA	  microbial	   community	  
studies	   with	   Quantitative	   Insights	   Into	   Microbial	   Ecology	   (QIIME)	   (17)	   and	   StarCluster	  
(http://star.mit.edu/cluster/).	  To	  exemplify	   the	  use	  of	   this	   technique,	  we	  analyzed	  the	   largest	  
effort	   to	   characterize	   human-­‐associated	   microbial	   communities,	   the	   Human	   Microbiome	  
Project	  (HMP)	  (25).	  We	  also	  used	  this	  new	  technique	  to	  combine	  other	  studies,	  specifically	  fecal	  
samples	  from	  pregnant	  women	  and	  a	  temporal	  study	  focusing	  on	  the	  development	  of	  an	  infant,	  
with	   the	   HMP.	   This	   ability	   to	   combine	   individual	   studies	   with	   the	   massive	   HMP	   dataset	  
concerning	  the	  “normal”	  adult	  microbiome	  allows	  new	  insight	  into	  how	  microbial	  communities	  
change	  during	  pregnancy	  and	  during	  the	  development	  of	  an	  infant	  over	  time.	  
QIIME	  and	  StarCluster	  in	  Amazon	  EC2	  
QIIME	   provides	   researchers	   with	   a	   one-­‐stop	   solution	   for	  microbial	   community	   analyses.	   The	  
main	  steps	  of	  the	  QIIME	  workflow	  are	  (1)	  preprocessing,	  which	  include	  sequence	  quality	  control	  
and	   demultiplexing	   into	   individual	   samples;	   (2)	   clustering	   sequences	   at	   different	   thresholds	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using	  several	  algorithms	  for	  either	  de-­‐novo	  or	  a	  reference	  clustering;	  (3)	  building	  phylogenetic	  
trees	  from	  the	  representative	  sequences	  of	  each	  cluster;	  and	  (4)	  performing	  phylogenetic	  and	  
non-­‐phylogenetic	  α-­‐	  and	  β-­‐diversity	  analyses	  and	  visualizations	  of	  these	  analyses	  (Figure	  7).	  




Figure	   7.	   QIIME	   workflow.	   The	   main	   steps	   are:	   (1)	   preprocessing,	   which	   include	   sequence	  
quality	   control	   and	  demultiplexing	   into	   individual	   samples;	   (2)	   clustering	  of	   the	   sequences	   at	  
different	   thresholds	   by	   either	   doing	   a	   de-­‐novo	   or	   a	   reference	   clustering;	   (3)	   building	  
phylogenetic	   trees	   from	   the	   representative	   sequences	   of	   each	   cluster;	   and	   (4)	   doing	  
phylogenetic	  and	  non	  phylogenetic	  α	  and	  β	  analysis	  and	  visualizations	  of	  the	  samples	  
	  
Amazon	  EC2	  provides	  different	   instance	  sizes,	  which	  range	  from	  micro	   instances	   (1	  cores	  and	  
613	   MB	   of	   memory)	   to	   high-­‐memory	   quadruple-­‐large	   instances	   (8	   cores	   and	   68.4	   GB	   of	  
memory).	  This	  cloud-­‐computing	  vendor	  allows	  users	  to	  create	  as	  many	  instances	  as	  desired,	  but	  
does	  not	  provide	  easy	  interconnectivity	  among	  instances.	  This	  lack	  of	  interconnectivity	  makes	  it	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difficult	  to	  create	  large	  compute	  clusters	  for	  large	  analytical	  processes.	  StarCluster	  provides	  this	  
ability	   based	   on	   simple	   configuration	   files	   and	   using	   a	   small	   number	   of	   command	   lines.	  
StarCluster	  allows	  users	  to	  create	  clusters	  based	  on	  any	  size	  instance,	  and	  interconnects	  them	  
via	   the	   Oracle	   Grid	   Engine	   queuing	   system	   (Figure	   8).	   To	   illustrate	   the	   possibilities	   of	   this	  
combination	   of	   QIIME,	   StarCluster	   and	   EC2,	   I	   will	   discuss	   the	   analysis	   of	   the	   HMP	   using	   this	  
technique	  in	  the	  next	  section.	  
	  
 
Figure	   8	   QIIME	   and	   StarCluster	   in	   Amazon	   EC2	   provides	   larger-­‐scale	   sequence	   analyses	   for	  
microbial	  ecology.	  In	  dark	  blue,	  the	  pipeline	  that	  researchers	  could	  follow	  to	  analyze	  their	  own	  
individual	  microbial	   community	  datasets	  using	   the	  de-­‐novo	  OTU	  picking	  pipeline	   in	  QIIME.	   In	  
gray,	   the	   steps	   to	   combine	   and	   compare	  microbial	   community	   studies	   using	   StarCluster	   and	  
EC2.	  
	  
The	  Human	  Microbiome	  Project	  
The	  HMP	  is	  a	  $185	  million	  project	  from	  the	  National	  Institutes	  of	  Health	  to	  fully	  characterize	  the	  
microbial	  communities	  inhabiting	  300	  healthy	  individuals	  (25).	  They	  collected	  samples	  from	  300	  
adults,	   of	  whom	  242	  were	   included	   in	   the	   initial	   publication	   (278),	   extracted	  DNA,	   and	   PCR-­‐
amplified	  bacterial	  DNA	  from	  two	  variable	   regions	   (V13	  and	  V35)	  of	   the	  16S	  rRNA	  gene.	  As	  a	  
result	   of	   this	   4	   year	   enterprise	   the	  HMP	  published	   two	  main	   articles	   (278,	   279).	   In	   (279)	   the	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authors	  presented	  the	  analysis	  results	  from	  their	  16S	  rRNA	  survey,	  combined	  with	  the	  shotgun	  
metagenomic	   survey.	   This	   analysis	   was	   performed	   on	   the	   Lawrence	   Berkeley	   National	  
Laboratory	  cluster	  Hopper,	  because,	  at	  the	  time	  the	  analysis	  was	  needed,	  they	  were	  uniquely	  
able	  to	  provide	  a	  sufficiently	  large	  and	  stable	  environment	  to	  perform	  this	  analysis	  using	  QIIME.	  
The	  main	   cluster	   characteristics	  we	  needed	  were:	  a	   shared	  hard-­‐drive	   space	  accessible	  by	  all	  
the	  nodes,	  ability	  to	  process	   jobs	  submitted	  from	  the	  nodes,	  at	   least	  4G	  of	  memory	  per	  node	  
for	  the	  parallel	  steps,	  and	  up	  to	  64G	  of	  RAM	  for	  the	  single-­‐threaded	  processes.	  
As	  a	  demonstration	  of	   the	   technique	  described	   in	  Figure	  8A,	  we	   reanalyzed	   the	  V35	   samples	  
from	  the	  16S	  rRNA	  data	  obtained	  by	  the	  HMP.	  The	  full	  analysis,	  going	  from	  raw	  sequences	  to	  
the	  unweighted	  UniFrac	  Principal	  Coordinate	  Analysis	  (PCoA)	  plots	  (Figure	  9A),	  took	  close	  to	  40	  
days	   and	   used	   2	   high	   memory	   quadruple	   large	   instances	   from	   Amazon	   EC2.	   This	   analysis	  
resulted	  in	  a	  charge	  of	  $2,496.00	  USD,	  which	  represents	  only	  about	  0.001%	  of	  the	  original	  HMP	  
budget.	  Being	  able	  to	  do	  this	  processing	  on	  commercial	  rather	  than	  government	  systems	  was	  
not	   possible	   last	   year,	   but	   this	   pipeline	   makes	   the	   ability	   to	   process	   these	   vast	   datasets	  
available	  to	  anyone,	  at	  modest	  cost.	  Additionally,	  we	  performed	  a	  sample	  rarefaction	  analysis	  
for	   the	   HMP	   (Figure	   9B).	   In	   this	   analysis,	   we	   showed	   that	   the	   HMP	   captured	   most	   of	   the	  




Figure	   9.	   UniFrac	   (36)	   β	   diversity	   PCoA	   plot	   that	   shows	   that	   the	   biggest	   difference	   in	   the	  
microbial	   community	   in	   the	   human	   body	   are	   due	   to	   the	   source,	   i.e.	   the	   body	   site,	   of	   the	  
community.	  B.	  Sample	  rarefaction	  per	  body	  site	  of	  the	  HMP,	  where	  we	  can	  see	  that	  the	  HMP	  
captured	  most	  of	  the	  possible	  variation	  in	  the	  healthy	  human	  microbiome	  per	  body	  site	  (i.e.	  the	  
amount	  of	  richness	  added	  with	  additional	  sequences	  approaches	  zero	  as	  additional	  samples	  are	  
added). 
	  
The	  development	  of	  an	  infant’s	  gut	  microbiome	  
Another	   fundamental	  question	   in	  human	  microbial	  ecology	   is	  how	   the	  different	   communities	  
within	  body	  sites	   form,	  and	  how	  they	  vary	  during	  day-­‐to-­‐day	  activities.	  To	  start	  assessing	  this	  
question,	  our	  collaborator	  Maria	  Gloria	  Dominguez-­‐Bello	  at	  the	  University	  of	  Puerto	  Rico	  (103)	  
sampled	  mothers	  at	  3	  body	   sites	   (oral,	   vaginal	  and	   skin)	  an	  hour	  before	   they	  gave	  birth,	  and	  
their	  babies	  at	  3	  body	  sites	   (oral,	  skin,	  nasopharyngeal	  aspirate)	  within	  20	  minute	  after	  birth.	  
The	   babies	   were	   delivered	   vaginally	   or	   by	   C-­‐section.	   The	  microbial	   community	   samples	   that	  
came	  from	  the	  vaginally	  delivered	  babies	  resembled	  the	  vaginal	  communities	  of	  their	  mothers,	  
whereas	  samples	  that	  came	  from	  the	  C-­‐section	  babies	  resembled	  the	  skin	  communities	  of	  the	  
mothers.	   The	   next	   piece	   of	   this	   puzzle	   was	   when	   our	   collaborator	   Ruth	   Ley	   at	   Cornell	   (83)	  
collected	  fecal	  samples	  over	  the	  first	  27	  months	  of	  the	  life	  of	  one	  single	  newborn,	  and	  showed	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how	  the	  fecal	  communities	  of	   the	  baby	  began	  as	  very	  different	  communities	   from	  adult	   fecal	  
communities	  (e.g.	  that	  of	  the	  mother),	  but,	  as	  the	  child	  got	  older,	  his	  fecal	  communities	  began	  
to	  resemble	  the	   fecal	  community	  of	   the	  mother	  both	   in	  diversity	  and	   in	  which	  microbial	   taxa	  
and	  functions	  were	  prevalent.	  
A	   more	   recent	   study	   from	   the	   Ley	   lab	   (280)	   added	   another	   perspective	   to	   this	   question	   of	  
microbial	   changes	   over	   time.	   This	   study	   reported	   how	   the	   fecal	   microbial	   communities	   of	  
healthy	  mothers	   changed	  dramatically	   between	   the	   first	   trimester	   and	   the	   third	   trimester	   of	  
pregnancy	   (the	   same	   subjects	   were	   sampled	   in	   both	   trimesters).	   We	   used	   the	   method	   to	  
combine	  studies	  described	   in	  Figure	  8	   to	  compare	   these	  new	  samples	  with	   the	   fecal	   samples	  
collected	  by	  the	  HMP	  using	  both	  variable	  regions.	  This	  combined	  analysis	  showed	  that	  the	  1st	  
trimester	   samples	   look	   more	   similar	   to	   those	   of	   the	   healthy	   individuals	   in	   the	   HMP,	   even	  
disregarding	   the	   difference	   in	   DNA	   extraction	   protocols,	   primers,	   and	   other	   methodological	  
differences,	  than	  do	  those	  of	  the	  3rd	  trimester	  (Figure	  10).	  This	  finding	  reinforces	  the	  point	  that	  
the	  effect	  size	  of	  the	  difference	  between	  the	  fecal	  communities	  in	  the	  first	  and	  third	  trimester	  is	  




Figure	   10.	   The	   HMP	   combined	   with	   (280)	   using	   the	   protocol	   described	   in	   Figure	   2B.	   In	   this	  
weighted	  UniFrac	   PCoA	   plot,	   the	   fecal	   samples	   from	  mothers	   in	   their	   1st	   trimester	   are	  more	  
similar	   to	   those	   of	   healthy,	   non-­‐pregnant	   individuals	   than	   those	   from	   the	   3rd	   trimester.	  
Pregnancy	  was	  an	  exclusion	  criterion	  in	  the	  HMP.	  
	  
Additionally,	  to	  show	  the	  power	  of	  combining	  studies,	  we	  collated	  all	  the	  V35	  samples	  from	  the	  
HMP	  with	  the	  samples	  from	  (83).	  This	  new	  meta-­‐analysis	  helped	  us	  gain	  a	  better	  understanding	  
of	  how	  the	  microbial	  content	  of	  the	  fecal	  communities	  of	  a	  newborn	  moves	  slowly	  from	  looking	  
like	  the	  microbial	  communities	  of	  body	  sites	  most	  associated	  with	  its	  delivery	  mode	  (i.e.	  vaginal	  
or	  skin)	  towards	  the	  fecal	  microbial	  communities	  of	  healthy	  individuals.	  With	  the	  results	  of	  this	  
analysis,	  we	  constructed	  the	  first	  video	  that	  illustrates	  how	  this	  change	  happens	  (screenshot	  in	  




Figure	  11.	  Screenshot	  of	  the	  video	  showing	  the	  results	  from	  combining	  the	  HMP	  with	  (83).	  	  The	  
full	  video	  can	  be	  found	  at	  http://www.youtube.com/watch?v=Pb272zsixSQ	  
	  
Conclusions	  
In	   this	  chapter,	  we	  have	  demonstrated	  a	  new	  technique	  allowing	  us	   to	  combine	  multiple	  16S	  
rRNA	   studies	   using	   QIIME	   and	   StarCluster,	   and	   run	   the	   analyses	   on	   Amazon	   EC2.	   This	   new	  
technique	   provides	   the	   opportunity	   for	   any	   researcher	   with	   a	   credit	   card	   to	   analyze	   large	  
microbial	  community	  datasets	  in	  a	  simple	  and	  inexpensive	  manner.	  Additionally,	  we	  presented	  
examples	  of	  how	  this	  technique	  has	  helped	  researchers	  to	  gain	  insight	  into	  the	  development	  of	  
the	  fecal	  microbial	  communities	  of	  infants,	  and	  the	  effect	  that	  pregnancy	  had	  on	  their	  mothers,	  
by	  combining	  samples	  from	  different	  studies.	  Finally,	  we	  have	  shown	  how	  animations	  of	  these	  




In	  the	  next	  chapter	  I	  will	  present	  Evident,	  a	  new-­‐web	  based	  computational	  tool	  to	  identify	  the	  
sampling	  effort	   required	   to	   identify	   relevant	  variables	  with	  an	  effect	   size	  defined	  by	  previous	  
previously	  published	  studies.	  This	  tool	  will	  help	  not	  only	  help	  microbial	  ecologists	  but	  any	  other	  
research	   field	   based	   on	   DNA	   sequencing	   across	   samples	   that	   can	   be	   divided	   into	   groups	   by	  
categorical	  variables,	  because	  the	  goal	  is	  to	  estimate	  how	  many	  sequences	  and	  samples	  would	  
be	  required	  in	  order	  to	  reproduce	  the	  major	  conclusions	  from	  past	  studies.	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CHAPTER	  
VII. Evident:	  elucidating	  sampling	  effort	  for	  microbial	  analysis	  studies	  
A	   daunting	   question	   that	   confronts	  microbial	   ecologists	  when	   designing	   their	   studies	   is	   how	  
many	   sequences	  and	   samples	   are	   sufficient	   to	  observe	  a	   specific	   effect	   size.	  An	  effect	   size	   is	  
defined	   as	   the	   difference	   between	   groups	   of	   samples,	   such	   as	   the	   separation	   in	   β	   diversity	  
between	   samples	   within	   groups	   of	   a	   study.	   Here	   we	   present	   Evident,	   an	   interactive	   web	  
application	   that	   allows	   us	   to	   graphically	   and	   statistically	   determine	   how	  many	   samples	   and	  
sequences	   would	   have	   been	   necessary	   in	   order	   to	   find	   the	   effects	   reported	   in	   published	  
studies.	   Results	   are	   presented	   in	   jackknifed	   plots,	  with	  multiple	   iterations	   to	   show	   statistical	  
differences	   in	   β	   diversity.	   Using	   this	   tool,	   researchers	   can	   focus	   the	   sampling	   effort	   of	   new	  
studies	  by	  relying	  on	  previously	  published	  data	  to	  capture	  specific	  differences	  between	  samples	  
using	  statistical	  certainty.	  
Introduction	  
Improvements	  in	  high-­‐throughput	  sequencing	  technologies	  have	  allowed	  researchers	  to	  move	  
from	  studies	  using	  a	  few	  samples	  to	  hundreds	  or	  thousands	  of	  samples	  (1).	  The	  ability	  to	  rapidly	  
sequence	  more	  samples	  has	  given	  researchers	  the	  opportunity	  to	  study	  new	  areas,	  such	  as,	  the	  
subtle	  differences	  between	  lean	  and	  obese	  twins	  (5),	  the	  possibility	  of	  forensic	  identification	  of	  
individuals	   via	   the	   surfaces	   they	   touch	   (75),	   and	   the	   full	   characterization	   of	   the	   microbial	  
inhabitants	   of	   the	   human	  body	   (279).	   These	   studies	   have	   also	   created	   a	   resource	   that	   other	  
researchers	   can	   exploit	   to	   design	   new	   but	   related	   studies,	   using	   the	   inferred	   effect	   sizes	   to	  
choose	   the	   right	   amount	   of	   samples	   and	   sequences	   per	   sample,	   and	   avoid	   unnecessary	  
expenditure	  of	  funds	  and	  effort.	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The	   current	   tools	   that	   could	   in	   principle	   allow	   this	   kind	   of	   exploration	   require	   extensive	  
interaction	   from	   the	   user,	   together	   with	   a	   deep	   understanding	   of	   individual	   scripts	   and	  
parameters	  to	  make	  these	  comparisons,	  as	  reviewed	  in	  (1).	  Furthermore,	  the	  user	  would	  need	  
to	  rely	  on	  a	  complex	  storage	  tree	  to	  compare	  the	  published	  results	  to	  the	  new	  ones	  based	  on	  
the	  new	  set	  of	  parameters.	  Therefore,	  we	  created	  Evident,	  which	  allows	  the	  user	  to	  interact,	  via	  
a	   web	   graphical	   user	   interface	   (GUI),	   with	   published	   studies	   and	   a	   diverse	   combination	   of	  
parameters	  (i.e.,	  sequences	  per	  sample,	  subjects,	  samples	  per	  subject)	  to	  recalculate	  single	  	  and	  
multiple	   iteration	   β	   diversity	   Principal	   Coordinate	   Analysis	   (PCoA)	   plots	   using	   unweighted	  
UniFrac	   as	   a	   metric	   of	   dissimilarity.	   The	   single-­‐iteration	   Evident	   workflow	   starts	   with	   the	  
original	   OTU	   table,	   rarefies	   based	   on	   the	   selection	   of	   samples	   and	   sequences	   per	   sample,	  
calculates	   unweighted	   UniFrac	   distances	   between	   all	   the	   samples,	   computes	   the	   PCoA	   axes,	  
and	   creates	   the	   WebGL	   output	   to	   display	   with	   the	   combination	   of	   the	   axis	   and	   the	   study	  
metadata.	  The	  multiple-­‐iteration	  version	  of	  the	  workflow	  repeats	  the	  single-­‐version	  workflow,	  
as	  many	  as	  the	  user	  selected,	  then	  estimates	  the	  average	  standard	  deviation	  of	  the	  centroids	  
for	  each	  ball,	  in	  3D	  because	  three	  axes	  are	  displayed,	  and	  creates	  confidence	  ellipsoids	  around	  
the	  final	  centroid	  of	  each	  sample.	  	  
Evident	  
Evident	  is	  a	  web-­‐based	  software	  tool	  with	  an	  interactive	  user	  interface,	  implemented	  in	  HTML,	  
Web	   Graphics	   Library,	   mod_python	   and	   Quantitative	   Insights	   Into	   Microbial	   Ecology	  
(QIIME)(17).	  The	  interface	  of	  Evident	  (Fig	  7A)	  is	  comprised	  of:	  (i)	  the	  selction	  of	  parameters	  (i.e.,	  
study	   of	   interest,	   number	   of	   sequences	   per	   sample,	   the	   number	   of	   samples	   to	   use,	   and	   the	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number	  of	  iterations);	  (ii)	  the	  kind	  of	  visualizations	  to	  generate	  (Demo	  PCoA	  shows	  the	  original	  
results	   from	  the	  study,	  and	  PCoA	  recalculates	  the	  study	  using	  the	  user-­‐defined	  parameters	   in	  
(i);	  (iii)	  the	  WebGL	  plot	  display.	  
	  
	  
Figure	  12.	  Evident	  GUI	  and	  illustration	  of	  the	  reanalysis	  of	  (75).	  A.	  Main	  GUI	  and	  demo	  version	  
of	   the	   study	  of	   interest;	  A1.	   Selections	   for	   study,	   sequences	  per	   sample,	  number	  of	   subjects,	  
samples	   per	   subject	   and	   number	   of	   iteration;	   A2.	   Analysis	  Menu:	   Demo	   (view	   original	   study	  
results),	  PCoA	  plots	  and	  alpha	  rarefaction	  plots	  (not	  implemented);	  C)	  Output	  area	  showing	  the	  
webGL	  PCoA	  plot.	   B.	   Effect	   of	   rarefaction	  on	  β	   diversity;	   B1.	   10	   sequences	   per	   sample	   show	  
recovery	  of	  the	  main	  patterns	  in	  the	  data	  set;	  B2.	  100	  sequences	  per	  sample	  with	  3	  iterations	  
we	   get	   back	   most	   of	   the	   pattern	   but	   it	   is	   clear	   that	   this	   result	   can	   be	   stochastic;	   B3.	   950	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sequences	  with	  3	  iterations	  clearly	  show	  that	  at	  this	  threshold	  the	  randomness	  of	  the	  result	  is	  
eliminated.	  
	  
To	  exemplify	  the	  power	  of	  Evident,	  we	  use	  the	  β	  diversity	  plots	  for	  (75)	  where	  the	  researchers	  
were	  able	  to	  identify	  individuals	  and	  the	  surfaces	  they	  touch	  daily	  by	  the	  bacterial	  communities	  
on	  their	  hands	  by	  using	  104	  samples	  with	  107,293	  sequences	  (Fig	  7A3).	  Using	  Evident,	  we	  show	  
that	   to	   recover	   the	   patterns	   seeing	   in	   this	   study,	   one	   could	   use	   as	   few	   as	   10	   sequences	   per	  
sample	   (Fig.	   7B1),	   as	   discussed	   in	   a	   previous	   study	   (281).	   This	   result	   can,	   however,	   change	  
dramatically	   depending	  on	   the	   sequences	   randomly	   selected.	   To	  demonstrate	   this	   effect,	  we	  
used	  100	  sequences	  per	  sample	  and	  performed	  3	   iterations	  to	  see	  the	  variation	  among	  them	  
(Fig.	   7B2).	   In	   this	   analysis,	   the	   span	   of	   the	   each	   sample,	   as	   represented	   by	   the	   confidence	  
ellipsoids,	  is	  large,	  however;	  it	   is	  usually	  still	  possible	  to	  differentiate	  the	  3	  individuals.	  Finally,	  
to	  make	  the	  best	  sampling	  effort	  more	  obvious	  for	  capturing	  the	  effect-­‐size	  within	  this	  study,	  
we	  used	  950	  sequences	  per	  sample	  and	  performed	  3	   iterations	  (Fig	  7B3),	  and	  as	  a	  result,	   the	  
individuals	  cluster	  separately	  and	  the	  confidence	  ellipsoids	  almost	  invisible	  (because	  they	  are	  so	  
small).	  
Conclusions	  
Evident	   provides	   a	   user-­‐friendly	   interface	   that	   allows	   for	   rapid,	   simple	   and	   effective	  
visualization	   of	   the	   sampling	   effort	   required	   to	   capture	   the	   effect-­‐size	   within	   a	   previously	  
published	   study.	  Using	   these	   features,	  microbial	   ecology	   researchers	   can	  better	   estimate	   the	  
necessary	  resources	  required	  for	  their	  study.	  Additionally,	  Evident	  will	  be	  a	  great	  resource	  for	  




Computational	  Biology	  (CB),	  together	  with	  Microbial	  Ecology	  (ME),	  are	  faced	  with	  the	  taxing	  but	  
fascinating	   task	   of	   managing	   the	   huge	   deluge	   of	   data	   produced	   by	   the	   advent	   of	   new	  
sequencing	   technologies.	  These	   technologies	  generate	   far	  more	   sequences	  per	   run	   than	  ever	  
before,	   increasing	   throughput	   by	   several	   orders	   of	  magnitude	   in	   the	   course	   of	   a	   decade.	   As	  
recently	  as	  a	   few	  years	  ago,	  ad	  hoc	   scripts	  and	  pipelines	  were	  enough	   to	  make	   sense	  of	   this	  
challenging	   task.	  However,	   as	   the	  datasets	   grew,	   this	   task	   became	  more	  demanding	   and	   the	  
need	   of	   introducing	   formal	   software	   engineering	   concepts	   into	   the	   pipeline	   development	  
became	  essential,	   as	   reviewed	   in	  Chapter	   1	   and	  2.	   Furthermore,	   CB	   researchers	  will	   need	   to	  
find	   new	  methods	   and	   algorithms	   to	  make	   sense	   of	   this	   amount	   of	   data	   in	   an	   efficient	   but	  
correct	  manner;	  for	  example,	  existing	  dimensionality	  reduction	  techniques	  suffice	  to	  compare	  
thousands	  of	  samples,	  but	  this	  step	  could	  become	  the	  bottleneck	  in	  the	  future	  when	  we	  try	  to	  
discern	  (dis)similarities	  between	  millions	  of	  samples,	  as	  reviewed	  in	  Chapter	  2.	  	  
Research	   in	   host-­‐associated	   ME	   has	   uncovered	   fascinating	   patterns	   linking	   host	   health	   to	  
bacterial	  communities.	  One	  of	  these	  interesting	  connections,	  as	  described	  in	  Chapter	  3,	   is	  the	  
relationship	   between	   the	  microbial	   organisms	   and	   the	   behavior	   of	   the	   host,	  which	   can	   even	  
include	  variations	  in	  cognition,	  personality,	  mood,	  sleep,	  and	  eating	  behavior.	  These	  variations	  
are	  not	  single	  snapshots	  of	  the	  communities	  but	   long-­‐lasting	  transformations	  of	  the	  host,	   the	  
microbiome	  and	  the	  environment;	  thus,	  the	  imperative	  need	  for	  doing	  further	  analyses	  of	  these	  
microbial	   effects	   on	   host	   behavior	   using	   spatial	   and	   temporal	   data	   sets	   in	   order	   to	   truly	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understand	  how	  these	  phenotypic	  changes	  are	  generated	  and	  their	  possible	  relationship	  with	  
genetics	  and	  the	  environment	  is	  clear.	  	  
The	   increasing	  need	   for	  understanding	   the	   spatial	   and	   temporal	   adaptations	  of	   the	  microbial	  
communities	   and	   their	   relationship	   to	   the	   host	   life	   events	   has	   led	   the	  ME	   research	   field	   to	  
collect	  more	  spatial	  and	  time	  explicit	  data;	  therefore	  creating	  a	  niche	  for	  new	  software	  tools	  to	  
combine	  and	  analyze	  these	  new	  aspects	  within	  the	  datasets,	  as	  detailed	  in	  Chapter	  4.	  The	  first	  
response	   to	   this	   need	   is	   to	   create	   pipelines	   that	   allow	   users	   to	   incorporate	   and	   study	   these	  
aspects	   in	  even	   larger	  datasets,	   for	  example	   combining	   the	   largest	   single	   survey	  of	   a	  healthy	  
human	  microbial	   community	  with	   another	   eight	   studies	   to	   discover	   the	   “Enterotypes”	   in	   the	  
human	   body	   or	   compare	   them	   to	   samples	   from	   different	   stages	   of	   pregnancy	   to	   see	   how	  
phenotypic	   changes	   reflect	   the	  microbial	   changes.	  Then,	   I	   created	   tools	   to	  better	  understand	  
these	   changes,	   including	   SitePainter,	   highlighted	   in	   Chapter	   5,	   that	   not	   only	   allows	   us	   to	  
understand	  the	  relationship	  between	  body	  sites	  but	  also	  allows	  us	  to	  comprehend	  some	  day-­‐to-­‐
day	  behaviors	   and	  how	  microbial	   transfers	  may	  occur,	   such	   as	   how	   skin	   communities,	  which	  
have	   been	   deeply	   altered	   by	   the	   environment	   of	   an	   individual	   may	   transform	   their	   facial	  
communities.	   Additionally,	   to	   add	   a	   temporal	   perspective	   to	   the	   development	   and	   constant	  
change	   of	   these	   communities,	   I	   put	   together	   the	   first	   moving	   pictures	   of	   the	   human	  
microbiome	  representing	  two	  adults	  and	  the	  development	  of	  an	  infants	  gut	  community	  against	  
communities	  of	  healthy	  adults,	  as	  detailed	  in	  Chapter	  6.	  
Another	  advantage	  of	  having	  access	  to	  this	  large	  collection	  of	  studies	  and	  their	  unified	  results	  is	  
that	  now	  we	  can	  layout	  future	  studies	  based	  on	  the	  size	  effect	  showed	  on	  them.	  For	  example,	  if	  
we	   have	   a	   new	   study	   that	   wants	   to	   show	   the	   difference	   between	   lean	   and	   obese	   twins	   in	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Burkina	  Faso	  we	  can	  find	  the	  right	  number	  of	  samples	  and	  sequences	  per	  sample	  to	  show	  these	  
differences,	  or	  if	  we	  want	  to	  show	  differences	  of	  these	  communities	  with	  gut	  disease	  patients,	  
assuming	  they	  have	  a	  similar	  effect	  size	  as	  the	  lean	  and	  obese	  twins.	  Today,	  we	  can	  use	  Evident,	  
described	  in	  Chapter	  7,	  to	  achieve	  this	  dream	  of	  fast	  study	  design	  with	  a	  visual	  and	  statistical	  
assurance	  that	  will	  capture	  these	  differences.	  
The	  rapid	  and	  continuing	  improvements	  in	  sequencing	  technologies	  allow	  microbial	  ecologists	  
not	   only	   to	   explore	   new	   environments	   but	   also	   expand	   the	   range	   of	   questions	   that	   can	   be	  
addressed.	   The	   two	  main	   areas	   in	  which	   I	   foresee	   this	   field	   expanding	   are:	   (1)	   being	   able	   to	  
understand	  the	  microbial	  patterns	  in	  healthy	  and	  disease	  states	  of	  the	  hosts,	  due	  to	  the	  meta-­‐
analysis	  of	  multiple	  studies	  and	  longer	  spatially	  and	  temporally	  explicit	  studies;	  and	  (2)	  querying	  
the	  samples	  for	  the	  existence	  of	  specific	  sequences	  or	  pathogens	   in	  specific	  samples.	  A	  major	  
challenge	  to	  the	  former	  area	   is	  the	  need	  for	  a	  similar	  methodological	  design	  (DNA	  extraction,	  
primers,	   sequencing	  methods	   etc.),	   a	   better	   understanding	   of	   how	   the	   different	   options	   and	  
parameters	  in	  the	  analytical	  pipeline	  affect	  the	  final	  results,	  a	  common	  defined	  vocabulary	  for	  
clinical	  data	  across	  all	  the	  studies,	  and	  an	  understanding	  of	  the	  relative	  effect	  sizes	  of	  technical	  
versus	   biological	   and	   clinical	   parameters.	   For	   the	   latter,	  we	  need	  better	   reference	  databases	  
and	  faster	  algorithms	  for	  comparing	  sequences,	  and	  an	  easier	  way	  to	  query	  these	  databases	  on	  
the	  fly.	  
The	  work	   presented	   in	   this	  manuscript	   not	   only	   highlights	   the	   state	   of	   the	   art	   in	   spatial	   and	  
temporal	   ME	   studies	   but	   also	   the	   newest	   computational	   tools	   to	   make	   sense	   of	   these	   vast	  
datasets.	   Additionally,	   it	   should	   encourage	  CB	   researchers,	   developers	   and	   software	  users	   to	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move	  towards	  fully	  tested	  and	  reproducible	  pipelines	  to	  achieve	  the	  dream	  of	  discovering	  the	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This	  tutorial	  illustrates	  the	  functional	  capabilities	  of	  SitePainter,	  where	  the	  user	  can	  load	  an	  SVG	  
image	  along	  with	  associated	  metadata	  (in	  tab-­‐delimited	  format).	  Once	  the	  data	  is	  loaded,	  the	  
user	  can	  color	  the	  image	  by	  the	  metadata	  using	  a	  color	  gradient.	  For	  this	  tutorial,	  we	  will	  use	  an	  
illustration,	  where	  we	  sampled	  regions	  of	  a	  human	  hand,	  followed	  by	  sequencing	  of	  the	  
microbial	  communities	  associated	  to	  each	  region.	  For	  the	  analysis	  of	  this	  sequence	  dataset	  we	  
analyzed	  the	  microbial	  diversity	  between	  regions	  (using	  principal	  coordinates	  analysis)	  and	  
taxonomic	  summaries	  for	  the	  microbial	  communities	  present	  in	  each	  region	  of	  human	  hand,	  
using	  the	  QIIME	  software	  package	  [PMID].	  
Getting	  Started	  
To	  begin	  this	  tutorial,	  you	  should	  first	  download	  and	  unzip	  the	  tutorial	  files	  
http://sitepainter.sourceforge.net/files/SitePainter_example_files.zip.	  Next,	  you	  should	  open	  
the	  SitePainter	  index.html.	  
Load	  Files	  
First,	  you	  must	  open	  the	  svg	  image	  of	  the	  hand	  (hand.svg)	  by	  clicking	  on	  the	  main	  menu	  and	  









Note:	  It	  should	  be	  noted	  that	  the	  “Import	  SVG”	  option	  does	  not	  behave	  properly	  so	  it	  is	  highly	  
recommended	  that	  users	  use	  the	  “Open	  Image”	  option.	  
	  
Now	  that	  the	  image	  is	  loaded,	  we	  need	  to	  open	  the	  associated	  metadata	  by	  clicking	  on	  the	  





The	  user	  should	  navigate	  to	  the	  tutorial	  files	  again	  and	  should	  select	  either	  the	  principal	  
coordinate	  file	  (hand_weighted_unifrac_pc.txt)	  or	  the	  summarized	  taxonomy	  file	  
(hand_otu_table_phylum.txt),	  which	  were	  produced	  by	  QIIME.	  For	  this	  tutorial,	  we	  will	  select	  




Note:	  It	  should	  be	  noted	  that	  user’s	  can	  also	  generate	  their	  own	  tab-­‐delimited	  metadata	  files.	  
	  
Once	  the	  user	  has	  opened	  the	  file,	  they	  should	  notice	  that	  the	  right-­‐menu	  under	  the	  “Meta.”	  







Now	  that	  the	  SVG	  and	  metadata	  have	  been	  loaded,	  we	  can	  color	  the	  principal	  coordinate	  axes	  
onto	  the	  hand	  image	  by	  select	  a	  principal	  coordinate	  vector	  from	  the	  drop-­‐down	  menu	  under	  
the	  “Meta.”	  tab	  in	  the	  right	  menu.	  To	  view	  the	  colors,	  the	  user	  should	  click	  on	  the	  “Color	  





Once	  the	  button	  has	  been	  clicked,	  the	  user	  should	  observe	  the	  colors	  have	  been	  painted	  onto	  











Now	  that	  we	  have	  painted	  the	  colors	  onto	  the	  hand	  image,	  we	  can	  also	  change	  the	  color	  



















Once	  the	  colors	  have	  been	  set,	  the	  user	  can	  recolor	  the	  image	  using	  the	  new	  colors,	  by	  clicking	  










Show/Hide	  Lines	  and	  Paths	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The	  user	  also	  has	  the	  ability	  to	  show/hide	  lines	  by	  selecting	  an	  option	  under	  the	  Lines	  field	  in	  








If	  the	  user	  wants	  to	  remove	  the	  paths	  within	  an	  image,	  they	  can	  select	  the	  “Hide”	  option	  under	  









Reset	  Image	  Colors	  
	  
Now	  that	  we	  have	  manipulated	  the	  colors	  of	  the	  image,	  we	  can	  reset	  the	  colors	  by	  clicking	  on	  
the	  “Color	  All”	  button	  under	  the	  Reset	  color	  field	  in	  the	  top-­‐menu.	  Additionally,	  users	  can	  
change	  the	  default	  reset	  color	  by	  clicking	  on	  the	  white	  box	  under	  the	  same	  field,	  which	  allows	  






Since	  there	  several	  principal	  coordinate	  vectors,	  the	  user	  may	  want	  to	  create	  an	  animation,	  
where	  each	  category	  is	  mapped	  onto	  the	  hand	  for	  a	  short	  amount	  of	  time,	  then	  it	  iterates	  to	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the	  next	  category.	  This	  allows	  the	  user	  to	  view	  the	  mapping	  of	  each	  category	  without	  having	  to	  
select	  and	  map	  each	  category	  onto	  the	  image.	  To	  generate	  an	  animation,	  the	  user	  should	  select	  




Next,	  we	  will	  select	  a	  few	  of	  the	  principal	  coordinate	  vectors	  we	  would	  like	  to	  map	  onto	  the	  





Now	  that	  we	  have	  selected	  the	  vectors	  we	  want	  to	  see	  mapped	  onto	  the	  hand,	  the	  user	  should	  












This	  completes	  the	  tutorial,	  where	  we	  illustrate	  many	  of	  the	  functionalities	  currently	  available	  
in	  SitePainter.	  I	  suggest	  the	  user	  repeats	  these	  steps,	  however;	  instead	  of	  opening	  the	  principal	  
coordinates	  file,	  I	  suggest	  the	  user	  opens	  the	  summarized	  taxonomy	  file	  
(hand_otu_table_phylum.txt)	  to	  visualize	  the	  Phylum-­‐level	  abundance	  at	  each	  region	  of	  the	  
hand.	  
	  
